US20060173490A1 - Filter system and method - Google Patents

Filter system and method Download PDF

Info

Publication number
US20060173490A1
US20060173490A1 US11/049,019 US4901905A US2006173490A1 US 20060173490 A1 US20060173490 A1 US 20060173490A1 US 4901905 A US4901905 A US 4901905A US 2006173490 A1 US2006173490 A1 US 2006173490A1
Authority
US
United States
Prior art keywords
lumen
valve
elongate
filter
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/049,019
Inventor
Daniel Lafontaine
Mark Jenson
William Drasler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US11/049,019 priority Critical patent/US20060173490A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DRASLER, WILLIAM J., JENSON, MARK L., LAFONTAINE, DANIEL M.
Priority to EP17173267.0A priority patent/EP3245978A1/en
Priority to PCT/US2006/000230 priority patent/WO2006083472A1/en
Priority to CA002596296A priority patent/CA2596296A1/en
Priority to EP06717435.9A priority patent/EP1855614B1/en
Priority to JP2007554096A priority patent/JP4991572B2/en
Priority to EP12179239.4A priority patent/EP2537486B1/en
Publication of US20060173490A1 publication Critical patent/US20060173490A1/en
Priority to US14/604,125 priority patent/US9622859B2/en
Priority to US15/257,498 priority patent/US20160374793A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/013Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • A61F2/2433Deployment by mechanical expansion using balloon catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/011Instruments for their placement or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/016Filters implantable into blood vessels made from wire-like elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal

Definitions

  • the present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve and filter apparatus, system, and method for use in the vasculature system.
  • Cardiac valves can become damaged and/or diseased for a variety of reasons. Damaged and/or diseased cardiac valves are grouped according to which valve or valves are involved, and the amount of blood flow that is disrupted by the damaged and/or diseased valve. The most common cardiac valve diseases occur in the mitral and aortic valves. Diseases of the tricuspid and pulmonary valves are fairly rare.
  • the aortic valve regulates the blood flow from the heart's left ventricle into the aorta.
  • the aorta is the main artery that supplies oxygenated blood to the body.
  • diseases of the aortic valve can have a significant impact on an individual's health. Examples of such diseases include aortic regurgitation and aortic stenosis.
  • Aortic regurgitation is also called aortic insufficiency or aortic incompetence. It is a condition in which blood flows backward from a widened or weakened aortic valve into the left ventricle of the heart. In its most serious form, aortic regurgitation is caused by an infection that leaves holes in the valve leaflets. Symptoms of aortic regurgitation may not appear for years. When symptoms do appear, it is because the left ventricle must work harder relative to an uncompromised aortic valve to make up for the backflow of blood. The ventricle eventually gets larger and fluid backs up.
  • Aortic stenosis is a narrowing or blockage of the aortic valve.
  • Aortic stenosis occurs when the valve leaflets of the aorta become coated with deposits. The deposits change the shape of the leaflets and reduce blood flow through the valve. Again, the left ventricle has to work harder relative to an uncompromised aortic valve to make up for the reduced blood flow. Over time, the extra work can weaken the heart muscle.
  • FIGS. 1A-1B illustrate an embodiment of a filter system.
  • FIGS. 2A-2B illustrate another embodiment of a filter system.
  • FIGS. 3A-3C illustrate another embodiment of the filter system.
  • FIGS. 4A-4D illustrate another embodiment of the filter system.
  • Embodiments of the present invention are directed to a filter system and method for temporary placement and use in a lumen. Embodiments of the present invention are also directed to augmenting cardiac valve function while filtering fluid moving within the lumen.
  • the filter system and method can be used to temporarily replace, or augment, an incompetent valve in a body lumen and/or can be used as a temporary valve during a procedure to repair or to replace an incompetent valve with a prosthetic valve.
  • Embodiments of the filter system can further include a sheath that can be used to help position the filter system within a body lumen, such as an artery or a vein, through minimally-invasive techniques.
  • additional structures can be used in conjunction with the filter system.
  • catheters having tissue shearing capability, stent delivery capability, and prosthetic valve delivery capability can also be used in conjunction with the filter system to aid in the replacement of a diseased native valve with a prosthetic valve.
  • the sheath can include a deployment rod to extend and retract the cardiac valve and filter. After replacement or repair of a native valve, the filter system can be retracted into the lumen of the sheath.
  • the filter system can be used to provide a temporary valve for replacement or repair of a diseased and/or damaged valve.
  • Other embodiments can be used to provide a temporary valve and filter during a procedure to repair a diseased or damaged valve or replace a diseased and/or damaged valve with a permanent valve.
  • the placement of the valve and filter apparatus within a body lumen e.g., within the aorta, adjacent the aortic valve, can help to provide for a temporary valve and filter to regulate fluid flow and filter particulate matter from fluid flowing through the aorta during transluminal cardiac valve repair and/or replacement.
  • FIGS. 1A and 1B illustrate one embodiment of a filter system 100 shown in perspective view.
  • Filter system 100 includes an elongate filter body 102 including an expandable filter region 150 and a valve 104 .
  • FIGS. 1A and 1B provide a perspective illustration of the valve 104 of filter system 100 in an open configuration ( FIG. 1A ) and a closed configuration ( FIG. 1B ).
  • the perspectives illustrated in FIGS. 1A and 1B show the filter system 100 in an expanded configuration, as will be discussed herein.
  • the elongate filter body 102 defines a lumen 106 extending from a proximal end 108 towards a distal end 110 .
  • the lumen 106 can be concentric with an elongate axis of the elongate filter body 102 .
  • the valve 104 also defines a lumen 112 .
  • the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body, where the lumen 112 of the valve 104 and the lumen 106 of the elongate filter body 102 can form a single lumen 114 .
  • the lumens 106 and 112 can be contiguous so as to form the single lumen 114 .
  • Other configurations are also possible.
  • filter system 100 allows for both unidirectional flow of fluid and filtering of the fluid passing through the lumens 106 and 112 .
  • the valve 104 includes a reversibly sealable opening 116 .
  • the reversibly sealable opening 116 can be formed by one or more valve leaflets 118 .
  • the valve leaflets 118 are configured to move between an open configuration (e.g., FIG. 1A , allowing fluid to flow in a first direction 193 through the lumens 106 and 112 ) and a closed configuration (e.g., FIG. 1B , preventing fluid from flowing in a second direction 197 opposite the first direction 193 ).
  • the valve 104 can include any number of configurations so as to define the lumen 112 and provide the reversibly sealable opening 116 for unidirectional flow of the fluid through the lumen 112 .
  • the valve 104 can include a frame 120 that supports a cover 122 .
  • the cover 122 defines the reversibly sealable valve leaflets 118 that provide for the unidirectional flow of a fluid through the lumen 112 of the valve 104 .
  • valve 104 Examples of a valve suitable for use as valve 104 is illustrated in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0020001, BSCI Docket No. 03-340US), and in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0120001, BSCI Docket No. 04-0080US), both of which are hereby incorporated by reference in their entirety.
  • frame 120 includes a variety of structural configurations. Generally, the frame 120 has a curved structural configuration, as will be discussed herein.
  • the frame 120 can include a first elliptical member 124 and a second elliptical member 126 , as illustrated in FIGS. 1A and 1B .
  • the first elliptical member 124 and the second elliptical member 126 meet at a first region 128 and a second region 130 , where the first region 128 and the second region 130 are opposite each other across axis 132 .
  • the first region 128 and the second region 130 can be located at any number of locations along the first elliptical member 124 and the second elliptical member 126 .
  • the first region 128 and the second region 130 can be at or near a minor axis of the first elliptical member 124 and the second elliptical member 126 .
  • the first region 128 and the second region 130 can be positioned away from the minor axis of the first elliptical member 124 and the second elliptical member 126 .
  • the frame 120 can include circular members that meet at the first region 128 and the second region 130 .
  • Other shapes besides elliptical and circular are also possible.
  • the first elliptical member 124 and the second elliptical member 126 meet at the first region 128 and the second region 130 at an angle 134 .
  • the size of angle 134 when the valve 104 is expanded can be selected based upon the type of body lumen and the body lumen size in which the valve 104 is to be placed. Additional factors include, but are not limited to, a longitudinal length 136 and a width 138 of the valve 104 . These factors, along with others discussed herein, can be used to provide the angle 134 that is sufficient to ensure that the first elliptical member 124 and the second elliptical member 126 have an appropriate expansion force against an inner wall of the body lumen in which the valve 104 is being placed.
  • the valve 104 also includes a flexible joint at and/or around axis 132 that allows the valve 104 to accommodate changes in body lumen size (e.g., diameter of the body lumen) by increasing or decreasing angle 134 when the valve 104 is expanded.
  • the frame 120 also has the ability to flex, as discussed herein, to allow for the distance between the first region 128 and the second region 130 to increase or decrease, thereby further accommodating changes in the body lumen size (e.g., diameter of the body lumen).
  • the frame 120 also provides sufficient contact and expansion force with the surface of a body lumen wall to encourage seating of the valve 104 and to prevent retrograde flow, i.e., second direction 197 , within the body lumen.
  • the frame 120 can be formed from a biocompatible metal, metal alloy, polymeric material, or combinations thereof, which allow the frame 120 to move radially between the collapsed and expanded state, as discussed herein.
  • the biocompatible metal, metal alloy, or polymeric material should exhibit a low elastic modulus and a high yield stress for large elastic strains that can recover from elastic deformations.
  • suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.
  • the frame 120 may be formed from a shape-memory material. Examples of a suitable shape-memory material include, but are not limited to, alloys of nickel and titanium in specific proportions known in the art as nitinol. Other materials are also possible.
  • the valve 104 can further include one or more radiopaque markers 152 (e.g., tabs, sleeves, welds).
  • one or more portions of the frame 120 can be formed from a radiopaque material.
  • Radiopaque markers can be attached to and/or coated onto one or more locations along the frame 120 . Examples of radiopaque materials include, but are not limited to, gold, tantalum, and platinum.
  • the position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of the valve 104 during its implantation.
  • the valve 104 further includes the cover 122 .
  • the cover 122 forms the valve leaflets 118 joined to valve frame 120 .
  • the valve leaflets 118 can deflect between a closed configuration ( FIG. 1B ) in which retrograde fluid flow through the valve 104 is restricted, and an open configuration ( FIG. 1A ) in which antegrade fluid flow through the valve 104 is permitted.
  • valve leaflets 118 of the valve are configured to open and close in response to the fluid motion and/or pressure differential across the valve leaflets 118 .
  • valve 104 shown in FIGS. 1A and 1B provide embodiments in which the surfaces defining the reversibly sealable opening 116 include a first leaflet 140 and a second leaflet 142 coupled to the valve frame 120 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 104 .
  • a two-leaflet configuration i.e., a bicuspid valve
  • FIGS. 1A-1B of the present invention show and describe a two-leaflet configuration for valve 104
  • designs employing a different number of valve leaflets e.g., tricuspid valve
  • the valve leaflets 118 can have a variety of sizes and shapes.
  • each of the valve leaflets 118 e.g., first leaflet 140 and second leaflet 142
  • each of the valve leaflets 118 need not have valve leaflets 118 that are of a similar size and shape (i.e., the valve leaflets can have a different size and shape).
  • Valve frame 120 can include an open frame construction (i.e., valve frame 120 defines an opening) through which valve leaflets 118 can radially-collapse and radially-expand.
  • the valve leaflets 118 can be provided over the open frame construction of the valve frame 120 to direct fluid flow through reversibly sealable opening 116 under specific fluid flow conditions.
  • the material of the valve leaflets 118 coupled to the valve frame 120 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets 118 for delivery by catheter to a location within a body lumen.
  • each of the valve leaflets 118 includes sufficient excess material spanning valve frame 120 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 118 forces the valve 104 into an open configuration ( FIG. 1A ).
  • Valve leaflets 118 can further include arcuate edges 144 and 146 , as shown in FIG. 1A , that are positioned adjacent each other along a substantially catenary curve between the first region 128 and the second region 130 in the closed configuration ( FIG. 1B ) of valve 104 .
  • arcuate edges 144 and 146 can help to define lumen 112 when the valve 104 is in the open configuration ( FIG. 1A ).
  • valve frame 120 in the open configuration the sufficient excess material spanning the valve frame 120 can allow the valve leaflets 118 to take on a semi-tubular structure, as shown in FIG. 1A , when fluid pressure opens the valve 104 .
  • arcuate edge 144 and 146 of valve 100 can open to approximately the full inner diameter of body lumen.
  • Each of the valve leaflets 118 can further include a curve imparted thereto so as to provide a concave structure 148 to the leaflet 118 .
  • the concave structure 148 allows the valve leaflets 118 to better collect retrograde fluid flow to urge valve leaflets 118 towards the closed configuration. For example, as retrograde flow begins, the valve leaflets 118 respond by moving towards the center of valve 104 . As the valve leaflets 118 approach the center of the device the valve leaflets 118 make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow.
  • the valve leaflets 118 can include one or more support structures.
  • the valve leaflets 118 can include one or more support ribs having a predetermined shape.
  • the predetermined shape of the support ribs can include a curved bias so as to provide the valve leaflets 118 with a curved configuration.
  • Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible when valve leaflets 118 are urged into an open position, and stiff when the valve leaflets 118 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve.
  • support ribs can also be attached to valve frame 120 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration.
  • the valve leaflets 118 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic.
  • Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like.
  • Possible biologic materials include, but are not limited to allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein.
  • Valve leaflets 118 can be coupled to the various embodiments of valve frame 120 , as described herein, in any number of ways.
  • a variety of fasteners can be used to couple the material of the valve leaflets 118 to the valve frame 120 .
  • Fasteners can include, but are not limited to, biocompatible staples, glues, and sutures.
  • the material of the valve leaflets 118 can be wrapped at least partially around the valve frame 120 and coupled using the fastener.
  • valve leaflets 118 can be coupled to the various embodiments of valve frame 120 through the use of heat sealing, solvent bonding, adhesive bonding, or welding the valve leaflets 118 to either a portion of the valve leaflet 118 (i.e., itself) and/or the valve frame 120 .
  • Valve leaflets 118 can also be attached to valve frame 120 according to the methods described in U.S. Patent Application Publication US 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety.
  • valve 104 can include three leaflets, with the various frames and covering configurations as described herein. Further, valve 104 can be configured to extend proximally and distally in a curvilinear manner to accommodate the coronary ostia and the diseased valve. For example, leaflets can extend past the coronary ostia in the central portion of the leaflets, and extend to accommodate the attachment points of the diseased valve by incorporating a tri-lobar saddle shaped configuration. In one embodiment, the valve 104 can include a configuration that allows the valve 104 to be place functionally distal to the coronary ostia for proper coronary perfusion, while maintaining sufficient clearance for the diseased valve and the repair or replacement of the diseased valve to be performed.
  • valve 104 Examples of a three leaflet valve suitable for use as valve 104 are illustrated in U.S. patent application Ser. No. ______, entitled “Valve Apparatus, System and Method” (BSCI Atty Docket No. 04-0223US and B&C Atty. Docket No. 201.0170001), and U.S. patent application Ser. No. ______, entitled “Cardiac Valve, System, and Method” (BSCI Atty Docket No. 03-487US and B&C Atty Docket No. 201.0070001), which is hereby incorporated by reference in its entirety.
  • a portion of the elongate filter body 102 can include an expandable filter region 150 to filter the unidirectional flow of the fluid moving through the valve 104 .
  • filtering of fluid can be accomplished through use of the expandable filter region 150 by trapping and/or inhibiting the passage of particular matter released into and/or present in the fluid moving through the valve 104 . Trapped particulate matter can then be removed with the filter system 100 through the lumen 106 .
  • the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body 102 .
  • the frame 120 of the valve 104 can be coupled to the expandable filter region 150 proximal the distal end 110 of the elongate filter body 102 .
  • Methods of coupling the frame 120 to the expandable filter region 150 of the elongate filter body 102 can be as described herein for coupling the valve leaflets 118 to the frame 120 .
  • the expandable filter region 150 can move between a first configuration (e.g., a compressed state, shown in FIG. 3A ) and a second configuration (e.g., an expanded state, shown in FIGS. 1A-1B and FIGS. 2A-2B ).
  • the expandable filter region 150 can expand from the first configuration to the second configuration due to force imparted by the frame 120 as it expands.
  • the expandable filter region 150 can expand from the first configuration to the second configuration by a combination of force imparted by the frame 120 as it expands and under pressure of the unidirectional flow of the fluid.
  • the force imparted by the frame when the valve is in the open configuration can help to maintain the expandable filter region expanded when under retrograde fluid flow, such as when the valve is in a closed configuration.
  • the expandable filter region 150 can be configured to radially self-expand when released from a compressed state.
  • the expandable filter region 150 in its deployed state can fill the cross-section area of the lumen in which the expandable filter region 150 and valve 104 are deployed.
  • filter region 150 in its deployed state can apply sufficient pressure to the inner wall of the lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 150 and the surface of the lumen wall.
  • the valve frame 120 can be used at least in part to apply the sufficient pressure to the inner wall of the body lumen.
  • the area and shape defined by the expandable filter region 150 e.g., the diameter of the expandable filter region
  • the area and shape defined by the expandable filter region 150 in its deployed state can be dependent upon the location in which the apparatus is intended to be used.
  • expandable filter region 150 examples include those having a woven, braided and/or a knit configuration as the same will be known and understood by one of ordinary skill in the art.
  • the expandable filter regions 150 can be formed of a material having pores formed therein or imparted thereto.
  • the expandable filter regions 150 can be formed of a number of materials. Materials can include polymers, such as ePTFE, PTFE, polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, PE, PET, silk, urethane, Rayon, Silicone, polyamid, mixtures, and block co-polymers thereof.
  • expandable filter region 150 can be configured to reduce passage of potentially injurious emboli to arteries feeding the brain, heart, kidneys, and other tissues and organs.
  • expandable filter region 150 can help to reduce or prevent passage of emboli greater than about 5 to 1000 micrometers in cross-sectional size.
  • Expandable filter region 150 may also prevent passage of emboli larger than 50 to 200 micrometers in cross-sectional size.
  • Multiple regions or layers of expandable filter region 150 may be incorporated to more efficiently filter emboli, such as a 200 micrometer portion of the expandable filter region 150 to capture larger particles and a 75 micrometer portion of the expandable filter region 150 to capture smaller particles.
  • expandable filter region 150 include the radially self-expanding configurations formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range. Examples of such materials include, but are not limited to, nitinol and nitinol-type metal alloys.
  • self-expanding configurations for the expandable filter region 150 include those having a spring-bias imparted into the members forming the filter region 150 .
  • the expandable filter region 150 can have a woven, braided and/or a knit configuration that can also impart a self-expanding aspect to the expandable filter region 150 .
  • the filter region 150 can further include radiopaque markers 152 .
  • radiopaque markers e.g., attached or coated
  • Other portions of filter system 100 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the filter system 100 .
  • the elongate filter body 102 can further include a fluid tight plug 154 positioned within the lumen 106 of the elongate filter body 102 .
  • the fluid tight plug 154 can be positioned proximal the expandable filter region 150 so as to occlude the lumen 106 , thereby directing the unidirectional flow of the fluid from the lumen 106 through the expandable filter region 150 .
  • the fluid tight plug 154 can have a variety of shapes and configurations.
  • a first end 155 and a second end 157 of the fluid tight plug 154 can include a flat planar surface.
  • the first end 155 of the fluid tight plug can include a conical configuration, as shown in FIGS. 1A and 1B .
  • Other shapes and configurations for the fluid tight plug 154 are also possible.
  • FIGS. 2A and 2B illustrate an additional embodiment of a filter system 200 .
  • FIGS. 2A and 2B provide a perspective illustration of the filter system 200 that includes both the elongate filter body 202 , as described herein, and the valve 204 .
  • the valve 204 includes a frame 220 and a cover 222 , including valve leaflets 240 and 242 (shown in FIG. 2A ), having a different configuration as compared to the valve 104 described above in FIGS. 1A and 1B .
  • valve 204 is illustrated in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0010001, BSCI Docket No. 03-341US), which is hereby incorporated by reference in its entirety.
  • the frame 220 of valve 204 includes an outer surface 256 and an inner surface 258 opposite the outer surface 256 .
  • the inner surface 258 defines the lumen 212 of the valve 204 for passing fluid therethrough.
  • the frame 220 also includes a first end 262 and a second end 260 .
  • the cover 222 can be located over at least the outer surface 256 of the frame 220 .
  • the cover 222 can extend around a perimeter of the frame 220 so as to completely cover the outer surface 256 of the frame 220 .
  • the cover 222 extends over the outer surface of the frame 220 so that there are no exposed portions of the outer surface 256 of the frame 220 .
  • the cover 222 can also be located over at least the inner surface 258 of the frame 220 .
  • a further embodiment includes the cover 222 located over at least the outer surface 256 and the inner surface 258 .
  • the frame 220 can include an open frame configuration that includes a first vertex 263 and a second vertex 264 relative the second end 260 of the frame 220 .
  • Frame 220 can further include a first valley 266 and a second valley 268 adjacent the second end 260 relative the first vertex 263 and the second vertex 264 .
  • the first vertex 263 and the second vertex 264 can be positioned opposite each other along a common axis 270 (shown in FIG. 2B ).
  • FIGS. 2A and 2B also illustrate that the first valley 266 and the second valley 268 can be positioned opposite each other and perpendicular to axis 270 .
  • first and second vertex 263 and 264 and the first and second valley 266 and 268 are also possible.
  • more than two vertexes and valleys may be included in the embodiments.
  • three valve leaflets e.g., a tricuspid valve
  • three vertexes and three valleys can also be included to help form the three leaflets.
  • the cover 222 can further include valve leaflets 240 and 242 that define the reversibly sealable opening 216 for the unidirectional flow of the fluid through the lumen 212 .
  • the surfaces of the cover 222 can be deflectable between a closed configuration ( FIG. 2B ) in which fluid flow through the lumen 212 can be restricted and an open configuration ( FIG. 2A ) in which fluid flow through the lumen 212 can be permitted in response to the fluid motion and/or pressure differential across the valve leaflets 240 and 242 .
  • valve 204 shown in FIGS. 2A and 2B provide embodiments in which the surfaces defining the reversibly sealable opening 216 include the first leaflet 240 and the second leaflet 242 coupled to the valve frame 220 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 204 .
  • a two-leaflet configuration i.e., a bicuspid valve
  • FIGS. 2A and 2B of the present invention show and describe a two-leaflet configuration for valve 204 , designs employing a different number of valve leaflets (e.g., tricuspid valve) are also possible.
  • each of the valve leaflets 240 and 242 include sufficient excess material spanning valve frame 220 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 240 and 242 forces the valve 204 into an open configuration ( FIG. 2A ).
  • Valve leaflets 240 and 242 further include arcuate edges, as illustrated in FIGS. 1A and 1B and shown as 144 and 146 , that are positioned adjacent each other along a substantially catenary curve between the first vertex 263 and the second vertex 264 in the closed configuration ( Figure B) of valve 204 .
  • arcuate edges 244 and 246 can help to define lumen 212 when the valve 204 is in the open configuration ( FIG. 2A ).
  • valve leaflets 240 and 242 in the open configuration can allow the valve leaflets 240 and 242 to take on a semi-tubular structure, as shown in FIG. 2A , when fluid pressure opens the valve 204 .
  • arcuate edge 244 and 246 of valve 204 can open to approximately the full inner diameter of body lumen.
  • Each of the valve leaflets 240 and 242 can further include a curve imparted thereto so as to provide a concave structure to the leaflet 240 and 242 .
  • the concave structure allows the valve leaflets 240 and 242 to better collect retrograde fluid flow to urge valve leaflets 240 and 242 towards the closed configuration ( FIG. 2B ).
  • the valve leaflets 240 and 242 respond by moving towards the center of valve 204 .
  • the valve leaflets 240 and 242 can make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow, i.e., second direction 197 as shown in FIGS. 1A and 1B .
  • FIGS. 3A and 3B provide a further illustration of the filter system 300 (i.e., the elongate filter body 302 , valve 304 , and filter region 350 ) that includes a sheath 374 having a lumen 376 .
  • FIGS. 3A and 3B provide a sectional illustration of the filter system 300 at least partially contained within a lumen 376 of the sheath 374 ( FIG. 3A ) and of the filter system 300 at least partially deployed from the lumen 376 of the sheath 374 ( FIG. 3B ).
  • both the valve 304 and the filter region 350 of the elongate filter body 302 can be releasably positioned in a coaxial arrangement within the lumen 376 of the sheath 374 .
  • the configuration of the support frame 320 provides the valve 304 with sufficient flexibility to move between the first configuration 342 (e.g., a retracted state within the lumen 376 of the sheath 374 as shown in FIG. 3A ) and the second configuration 344 (e.g., an extended state outside the lumen 376 of the sheath 374 as shown in Figures FIG. 3B ).
  • the valve 304 can be configured to reside in the compressed state when retracted within the lumen 376 of the sheath 374 , as illustrated in FIG. 3A , and in an expanded state when extended from the lumen 376 of the sheath 374 , as illustrated in FIG. 3B . In one embodiment, the valve 304 expands from its compressed state within the lumen 376 to the deployed state when the sheath 374 is retracted from around the valve 304 .
  • the sheath 374 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof.
  • the sheath 374 can have a wall thickness and an inner diameter sufficient to maintain both the valve 304 and the expandable filter region 350 in the retracted state when they are positioned within the lumen 376 .
  • the sheath 374 can further include radiopaque markers 352 .
  • radiopaque markers e.g., attached or coated
  • the support frame 320 of the cardiac valve 304 expands to increase the diameter 312 of the lumen 306 of the valve 304 as the valve 304 is extended from the sheath 374 .
  • the diameter 312 of the lumen 306 can be determined based upon the type of body lumen and the body lumen size in which the valve 304 is to be placed. In an additional example, there can also be a minimum value for the width for the support frame 320 that ensures that the valve 304 will have an appropriate expansion force against the inner wall of the body lumen to prevent retrograde flow within the body lumen.
  • the lumen 306 of the elongate filter body 302 in the filter region 350 also increases in diameter as the valve 304 and the elongate filter body 302 are extended from the sheath 374 .
  • the expandable filter region 350 can expand from the first configuration to the second configuration due in part to force imparted by the frame 320 as it expands and under pressure of the unidirectional flow of the fluid.
  • the expandable filter region 350 can be configured to radially self-expand, as the same has been described herein, when released from its compressed state within the lumen 376 of the sheath 374 .
  • the expandable filter region 350 in its deployed state can fill the cross-section area of a body lumen in which the valve 304 and expandable filter region 350 are deployed.
  • filter region 350 in its deployed state can apply sufficient pressure to the inner wall of the body lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 350 and the surface of the body lumen wall.
  • the area and shape defined by the expandable filter region 350 e.g., the diameter of the expandable filter in its deployed state will be dependent upon the location in which the filter system is intended to be used.
  • the filter system 300 can be extended and retracted from the lumen 376 of the sheath 374 in any number of ways.
  • the elongate filter body 302 can be pulled longitudinally within the lumen 376 of the sheath 374 so as to retract the valve 304 and the filter region 350 of the elongate filter body 302 .
  • the elongate filter body 302 supported by the sheath 374 , provides sufficient column strength to allow force imparted at the proximal end 308 of the elongate filter body 302 to retract the valve 304 and the filter region 350 .
  • a portion of the elongate filter body 302 extending from the filter region 350 to the proximal end 308 can be reinforced and/or have an alternative construction relative the filter region 350 so as to impart sufficient column strength to the elongate filter body 302 .
  • the elongate filter body 302 can then be pushed longitudinally within the lumen 376 of the sheath 374 so as to extend the valve 304 and the filter region 350 of the elongate filter body 302 .
  • valve 304 and the filter region 350 can be deployed and retracted by moving the sheath 374 relative the elongate filter body 302 .
  • the elongate filter body 302 can be held while the sheath 374 is moved longitudinally so as to either deploy or retract the valve 304 and the filter region 350 .
  • the filter system 300 and the sheath 374 can further include handles positioned at the proximal end 308 of the elongate filter body 302 and a first sheath end 378 of the sheath 374 .
  • the sheath 374 includes a handle 382 and the elongate filter body 302 includes a handle 384 .
  • Handles 382 and 384 allow the sheath 374 and the elongate filter body 302 to move relative to each other so as to extend and/or retract the valve and a portion of the elongate filter body from the lumen 376 of the sheath 374 .
  • the distance between the handles 382 and 384 can correspond approximately to the length of the compacted valve 304 and the filter region 350 to effectively deploy the expandable filter region 350 and valve 304 .
  • Other configurations and relational lengths are possible.
  • filter system 300 and the sheath 374 can further include a sleeve 386 having a slit 388 and a pull tab 390 positioned between the handles during delivery to prevent inadvertent exposure of the valve 304 and filter region 350 .
  • the sleeve 386 can be stripped from the filter system 300 by pulling the pull tab once the sheath 374 has been placed at the predetermined location at which the valve 304 and the filter region 350 are to be deployed.
  • Other removable structures for preventing inadvertent exposure of the valve 304 and filter region 350 are also possible.
  • the filter system 300 can be extended and/or retracted from the sheath 374 through the use of a deployment rod 394 .
  • the deployment rod 394 extends from the proximal end 308 of the elongate filter body 302 through the lumen 376 to the fluid tight plug 354 , as the same has been described in connection with FIGS. 1A and 1B .
  • the deployment rod 394 can be used to move the elongate filter body 302 and the valve 304 relative the sheath 374 .
  • the deployment rod 394 can extend through the lumen 312 to the fluid tight plug 354 , where the deployment rod 394 can be used to push the filter system 300 relative the sheath 374 to deploy the valve 304 and the filter region 350 and/or pull the filter system 300 relative the sheath 374 to draw the valve 304 and the filter region 350 back into its compressed state within the lumen 376 of the sheath 374 .
  • the deployment rod 394 can be used to change the position of the valve 304 and filter region 350 once deployed from a first position within the lumen to a second position.
  • the deployment rod 394 and the fluid tight plug 354 can further include releasably interconnecting members to allow the deployment rod 394 and the fluid tight plug 354 to be separated.
  • the fluid tight plug 354 can include a socket having threads to receive and interact with a threaded portion of the deployment rod 394 . This structure allows for the deployment rod 394 to be inserted through the lumen 376 of the elongate filter body 302 to the fluid tight plug 354 , where the treaded portion of the deployment rod 394 can be screwed into the threaded socket of the fluid tight plug 354 .
  • the deployment rod 394 can then be removed from the lumen 376 by unscrewing the threaded portion of the deployment rod 394 from the threaded socket of the fluid tight plug 354 .
  • other ways of decoupling the deployment rod 394 and the fluid tight plug 354 are also possible.
  • the deployment rod 394 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof.
  • the deployment rod 394 can be formed of medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.
  • FIGS. 4A-4D provides a further illustration of the filter system 400 that includes the sheath 474 , as previously discussed, and a catheter 401 and an apparatus 445 .
  • FIGS. 4A-4D provide perspective illustrations of the filter system 400 at least partially contained within the lumen 476 of the sheath 474 , with the catheter 401 and the apparatus 445 at least partially contained within a lumen 406 of the elongate filter body 402 .
  • the catheter 401 includes an elongate body 403 having a first lumen 405 extending between a proximal end 407 and a distal end 409 .
  • the first lumen 405 allows for additional elongate members to travel along a longitudinal axis of the elongate body 402 .
  • the catheter 401 further includes a first cutting head 411 having a blade 413 and an elongate pulling member 415 .
  • the first cutting head 411 can be positioned adjacent the distal end 409 of the elongate body 403 of the catheter 401 with the elongate pulling member 415 extending through the first lumen 405 .
  • the elongate pulling member 415 can slide within the first lumen 405 to move the first cutting head 411 relative the distal end 409 of the elongate body 403 of the catheter 401 .
  • the catheter 401 also includes a second cutting head 417 having a blade 419 .
  • the second cutting head 417 can be positioned adjacent the distal end 409 of the elongate body 403 between the distal end 409 and the first cutting head 411 .
  • the blade 413 of the first cutting head 411 can move relative the blade 419 of the second cutting head 417 to provide a shearing action.
  • the shearing action can be sufficient for cutting cardiac tissue.
  • FIG. 4A further illustrates an embodiment in which the second cutting head includes an elongate pushing member 421 .
  • the elongate pushing member 421 can slide within the first lumen 405 to move the second cutting head 417 relative the distal end 409 of the elongate body 403 and the first cutting head 411 .
  • the elongate pulling member 415 can be arranged concentrically with the elongate pushing member 421 in the first lumen 405 .
  • the elongate pulling member 415 , the elongate pushing member 421 and the first lumen 405 of the elongate body 403 can be positioned coaxially.
  • the lumen 405 has a diameter sufficient to accommodate the elongate pushing member 421 .
  • the elongate pushing member 421 had a diameter sufficient to accommodate the elongate pulling member 415 .
  • the elongate pulling member 415 and the elongate pushing member 421 can be structured such that their relative rotational movement is restricted.
  • relative axial rotation of the elongate pulling member 415 and the elongate pushing member 421 is restricted due to the structure of the members 415 and 421 .
  • this can be accomplished using one or more physical structures formed in and/or attached to the members 415 and 421 .
  • one of the members 415 or 421 can include a channel through which an extension from the other of the members 415 or 421 can travel so as to inhibit axial rotation of the members 415 and 421 .
  • the members 415 and 421 could have a cross-sectional shape that inhibits relative axial rotation. Examples of such cross-sectional shapes include oval or elliptical cross-sectional shapes. Other shapes are also possible.
  • a gap can exist between the opposing surfaces of the first lumen 405 and the elongate pushing member 421 to allow the elongate pushing member 421 to move through the first lumen 405 from force applied at the proximal end of the elongate pushing member 421 .
  • a gap can exist between the opposing surfaces of the elongate pushing member 421 and the elongate pulling member 415 to allow the elongate pushing member 421 and the elongate pulling member 415 to move relative each other from force applied at the proximal end of the elongate pushing member 421 and/or the elongate pulling member 415 .
  • the elongate pull member 415 can further include a lumen 471 for tracking over a guidewire.
  • a lubricant can be included on the surfaces of the elongate pulling member 415 , the elongate pushing member 421 and the first lumen 405 .
  • the first cutting head 411 further includes a shape conducive to passing the catheter 401 and the filter system 400 through a body lumen (e.g., a lumen of the cardiovascular system).
  • a body lumen e.g., a lumen of the cardiovascular system.
  • the first cutting head 411 can include a conical shape having a first end 423 and a second end 425 , where the first end 423 has a diameter that is less than a diameter of the second end 425 .
  • Other shapes are also possible.
  • the shape of the first cutting head 411 can be configured to protectively house the blade 413 from structures passing by the first end 423 towards the second end 425 .
  • the shape of the first cutting head 411 can be used to shield the blade 413 from unintentionally interfering and/or cutting tissue within a body lumen.
  • the blade 413 can be radially positioned relative the elongate pulling member 415 generally along the second end 425 of the first cutting head 411 .
  • the first cutting head 411 can include more than one blade 413 .
  • Each blade 413 and 419 further includes a cutting edge 427 and 429 , respectively, in alignment so as to provide shearing action between a pair of the cutting edges 427 and 429 of the blades 413 and 419 .
  • the first cutting head 411 can move relative the second cutting head 417 to allow the cutting edge 427 of the blade 413 of the first cutting head 411 to slide past the cutting edge 429 of the blade 417 of the second cutting head 417 .
  • suitable materials for the blades 413 and 419 include, but are not limited to, stainless steel (e.g., 316L) and titanium.
  • blades 413 and 419 can be secured to the first cutting head 411 and the second cutting head 417 , respectively, in any number of ways.
  • blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of mechanical fasteners, such as screws, and/or interlocking pins and sockets.
  • blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of chemical adhesives. Examples of such chemical adhesives include, but are not limited to, medical grade adhesives such as cyanoacrylate, acrylic, silicone, and urethane adhesives.
  • the first cutting head 411 can be configured to receive and house at least a portion of the second cutting head 417 , including the blade 419 , such that the second blade 419 does not pass beyond the first cutting head 411 .
  • the first cutting head can include a socket that extends radially relative the elongate pulling member 415 and distally from the blade 413 to receive the blade 419 of the second cutting head 417 as the blade 419 passes the blade 413 .
  • the blade 419 can be positioned within the socket of the first cutting head 411 as the catheter 401 is moved through a lumen.
  • Catheter 401 can have various lengths between the proximal end 407 and the first cutting head 411 .
  • the length between the proximal end 407 and the first cutting head 411 is sufficient to allow the catheter 401 to be percutaneously implanted through a patient's vasculature to position the cutting heads (e.g., the first and second cutting heads) at a predetermined location.
  • the predetermined locations include, but are not limited to, cardiovascular locations such as on or adjacent to a cardiac valve of the heart (e.g., the aortic valve), including within a chamber of the patient's heart (e.g., the left ventricle of the heart).
  • the length between the proximal end 407 and the first cutting head 411 will be dependent upon each patient's physiological structure and the predetermined location within the patient.
  • the elongate body 403 of the catheter 401 , the elongate pulling member 415 , the elongate pushing member 421 , the second cutting head 417 and the first cutting head 411 can be formed from a wide variety of materials and in a wide variety of configurations.
  • the materials may include, but are not limited to, one or more of polyvinyl chloride (PVC), polyethylene (PE), polyolefin copolymer (POC), polyethylene terephthalate (PET), polyamid, mixtures, and block co-polymers thereof.
  • the materials may include one or more alloys in any number of configurations.
  • the materials may include stainless steel (e.g., 316L), titanium, or other medical grade alloys as are known. These materials may also have a woven configuration or a solid extruded configuration.
  • the selection of material and configuration allows for the elongate body 403 , the elongate pulling member 415 , the elongate pushing member 421 , the second cutting head 417 and the first cutting head 411 to each have the flexibility, and the ability to be either pushed and/or pulled thereby accomplishing the actions described for the components herein.
  • selection of the material can be based generally on a broad range of technical properties, including, but not limited to, modulus of elasticity, flexural modulus, and Shore A hardness required for the embodiments of the present invention.
  • Components of the present apparatus and/or system can also be coated for lubrication, for abrasion resistance, or to deliver an anticoagulatory drug.
  • first cutting head 411 and second cutting head 417 can be accomplished by alternate cutting, shearing, slicing, grinding or ablative means as are known for other purposes.
  • thermal energy can be used to weaken or slice the diseased valve, rolling cutters could be incorporated, or a “cutting balloon” mechanism could be incorporated.
  • the catheter 401 can further include radiopaque markers 431 .
  • radiopaque markers e.g., attached or coated
  • radiopaque markers can be used to mark the location of blades 413 and 419 .
  • Other portions of catheter 401 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the catheter 401 .
  • catheter 401 can reside at least partially within the lumen 406 of the elongate filter body.
  • FIG. 4B provides an example in which both the valve 404 and the filter region 450 have been extended from the sheath 474 , as discussed herein, with the catheter 401 at least partially extending distally from the valve 404 .
  • the valve leaflets of valve 404 can seat around the elongate body 403 of the catheter 401 to provide the reversibly sealable opening of the valve 404 .
  • the elongate body 403 can travel longitudinally within the lumen 406 of the elongate filter body 402 to extend and retract the distal end 409 of the catheter 401 relative the valve 404 of the filter system 400 .
  • the elongate filter body 402 can further include a sealing ring that allows the elongate body 403 of the catheter 401 to move longitudinally while maintaining a fluid tight seal within the lumen 406 of the elongate filter body 402 .
  • the elongate body 403 of catheter 401 further includes a second lumen 435 , as shown in FIG. 4A .
  • the second lumen 435 can extend between the proximal end 407 and the distal end 409 of the elongate body 403 , where the second lumen 435 can be coupled in fluid tight communication to an inflatable balloon 437 on the elongate body 403 .
  • the catheter 401 can further include an inflation device 495 that can reversibly couple in fluid tight communication with the second lumen 435 to provide fluid pressure to inflate and deflate balloon 437 .
  • the inflatable balloon 437 can be positioned adjacent the distal end 409 of the elongate body 403 and proximal to the second cutting head 417 .
  • the inflatable balloon 437 can be inflated from a deflated state to an inflated state by pressure applied by fluid moving through the second lumen 435 .
  • the catheter 401 further includes an expandable stent 439 positioned over at least a portion of the inflatable balloon 437 .
  • the expandable stent 439 can move between a compressed state, as shown in FIG. 4B , and an expanded state, as shown in FIG. 4C , using the inflatable balloon 437 .
  • the expandable stent 439 can be deployed over cardiac tissue sheared using the first and second cutting heads 411 and 417 using the inflatable balloon 437 .
  • Catheter 401 can further include an annular push ring 441 positioned between the second cutting head 417 and the inflatable balloon 437 .
  • the annular push ring 441 can be used for contacting and moving at least a portion of cardiac tissue sheared with the first and second cutting heads 411 and 417 .
  • the first and second cutting heads 411 and 417 can be used to shear cardiac tissue (e.g., one or more cusps of a valve).
  • the annular push ring 441 can then be advanced into contact with the sheared cardiac tissue. As the annular push ring 441 advances the sheared cardiac tissue can be directed towards the wall of the lumen.
  • Stent 439 can then be positioned over at least a portion of the sheared cardiac tissue positioned using the annular push ring 441 . Stent 439 can then be deployed using the inflatable balloon 437 to position at least a portion of the sheared cardiac tissue between the expanded stent 439 and the wall of the lumen. As will be appreciated, the dimensions and physical characteristics of the stent 439 will be dependent upon the location in which the stent 439 is to be implanted.
  • the apparatus 445 can further include a cardiac valve 455 .
  • the cardiac valve 455 can be releasably positioned adjacent the expandable stent 439 over at least a portion of the inflatable balloon 437 .
  • cardiac valve 455 can be implanted within the fluid passageway of a body lumen, such as for replacement of a valve structure within the body lumen to regulate the flow of a bodily fluid through the body lumen in a single direction.
  • the cardiac valve 455 can be configured to reside in a compressed state over at least a portion of the inflatable balloon 437 . Using the inflatable balloon, the cardiac valve 455 can be expanded into a deployed state as illustrated in FIGS. 4C and 4D .
  • cardiac valve 455 includes valve 204 as described herein.
  • An additional embodiment of cardiac valve 455 is illustrated in U.S. patent application Ser. No. ______, entitled “Vascular Catheter, System, and Method” (B&C Docket No. 201.0080001, BSCI Docket No. 03-498US), which is hereby incorporated by reference in its entirety.
  • the cardiac valve 455 includes a support frame and a cover.
  • the cover of the cardiac valve 455 can be positioned over at least the outer surface of the support frame.
  • the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of the cardiac valve 455 .
  • the filter system 400 , catheter 401 and the apparatus 445 can further include handles to allow the various components to be moved relative each other.
  • handles 479 can allow the elongate pushing member 421 and/or the elongate pulling member 415 to be moved relative each other.
  • Handle 481 can allow the catheter 401 to be moved relative the apparatus 445 and the sheath 474 .
  • handles 483 can allow the sheath 474 and the filter system 400 to be moved relative each other.
  • other structures may be used in place of or in addition to the handles to allow the various components of the filter system 400 , catheter 401 , and apparatus 445 to move relative each other.
  • embodiments of the present invention further include methods for forming the filter system and apparatus, as discussed herein.
  • embodiments of the present invention can be formed by providing an elongate filter body that includes the expandable filter region defining a lumen.
  • the valve can further be provided, where the valve can be adjoined proximal the distal end of the elongate filter body to form a single lumen through which fluid flows unidirectionally through the valve and the elongate filter body to filter the fluid.
  • the valve can define a reversibly sealable opening for the unidirectional flow of fluid through the lumen of the valve.
  • the expandable filter region can be configured to move between a first configuration and a second configuration. In one embodiment, the movement from the first configuration to the second configuration can occur as the valve expands in addition to under pressure of the unidirectional flow of the fluid.
  • the elongate filter body can also be provided with the fluid tight plug to direct the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
  • the fluid tight plug can include various shapes and sizes and can be positioned according to the embodiments described herein.
  • the valve can be provided with a support frame having various configurations.
  • a first configuration can include a compressed configuration and a second configuration can include an expanded configuration.
  • expansion of the support frame can be supplemented by fluid flowing into the lumen of the elongate filter body.
  • the filter system and apparatus can further include providing the catheter having the first cutting head and the second cutting head, as discussed herein.
  • the first cutting head can include the blade and the elongate pulling member, where the first cutting head can be positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen of the catheter. The elongate pulling member can then slides within the first lumen to move the first cutting head relative the distal end of the elongate body.
  • the second cutting head can also include a blade, and be positioned adjacent the distal end of the elongate body between the distal end and the first cutting head. The blade of the first cutting head can be moved relative the blade of the second cutting head to provide the shearing action for cardiac tissue.
  • the catheter extends though the lumen of the elongate filter body and the lumen of the valve.
  • the filter system and apparatus further include providing a second lumen to the elongate body, where the second lumen can be in fluid tight communication with the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head.
  • the expandable stent can then be positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue.
  • the annular push ring can also be provided between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue.
  • the embodiments can also include providing the cardiac valve positioned over the inflatable balloon, where the cardiac valve can be deployed through the use of the inflatable balloon.
  • the support frame 120 and/or the cover 122 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.

Abstract

A filter system, comprising an elongate filter body defining a lumen and having a proximal end and a distal end. A valve can be provided defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen. The valve can be adjoined proximal the distal end of the elongate filter body, wherein the elongate filter body filters the unidirectional flow of the fluid passing through the lumen of the valve and the lumen of the elongate filter body.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve and filter apparatus, system, and method for use in the vasculature system.
  • BACKGROUND OF THE INVENTION
  • Cardiac valves can become damaged and/or diseased for a variety of reasons. Damaged and/or diseased cardiac valves are grouped according to which valve or valves are involved, and the amount of blood flow that is disrupted by the damaged and/or diseased valve. The most common cardiac valve diseases occur in the mitral and aortic valves. Diseases of the tricuspid and pulmonary valves are fairly rare.
  • The aortic valve regulates the blood flow from the heart's left ventricle into the aorta. The aorta is the main artery that supplies oxygenated blood to the body. As a result, diseases of the aortic valve can have a significant impact on an individual's health. Examples of such diseases include aortic regurgitation and aortic stenosis.
  • Aortic regurgitation is also called aortic insufficiency or aortic incompetence. It is a condition in which blood flows backward from a widened or weakened aortic valve into the left ventricle of the heart. In its most serious form, aortic regurgitation is caused by an infection that leaves holes in the valve leaflets. Symptoms of aortic regurgitation may not appear for years. When symptoms do appear, it is because the left ventricle must work harder relative to an uncompromised aortic valve to make up for the backflow of blood. The ventricle eventually gets larger and fluid backs up.
  • Aortic stenosis is a narrowing or blockage of the aortic valve. Aortic stenosis occurs when the valve leaflets of the aorta become coated with deposits. The deposits change the shape of the leaflets and reduce blood flow through the valve. Again, the left ventricle has to work harder relative to an uncompromised aortic valve to make up for the reduced blood flow. Over time, the extra work can weaken the heart muscle.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A-1B illustrate an embodiment of a filter system.
  • FIGS. 2A-2B illustrate another embodiment of a filter system.
  • FIGS. 3A-3C illustrate another embodiment of the filter system.
  • FIGS. 4A-4D illustrate another embodiment of the filter system.
  • DETAILED DESCRIPTION
  • Embodiments of the present invention are directed to a filter system and method for temporary placement and use in a lumen. Embodiments of the present invention are also directed to augmenting cardiac valve function while filtering fluid moving within the lumen. For example, the filter system and method can be used to temporarily replace, or augment, an incompetent valve in a body lumen and/or can be used as a temporary valve during a procedure to repair or to replace an incompetent valve with a prosthetic valve.
  • Embodiments of the filter system can further include a sheath that can be used to help position the filter system within a body lumen, such as an artery or a vein, through minimally-invasive techniques. In further embodiments, additional structures can be used in conjunction with the filter system. For example, catheters having tissue shearing capability, stent delivery capability, and prosthetic valve delivery capability can also be used in conjunction with the filter system to aid in the replacement of a diseased native valve with a prosthetic valve. In an additional embodiment, the sheath can include a deployment rod to extend and retract the cardiac valve and filter. After replacement or repair of a native valve, the filter system can be retracted into the lumen of the sheath.
  • The Figures herein follow a numbering convention in which the first digit or digits correspond to the drawing Figure number and the remaining digits identify an element or component in the drawing. Similar elements or components between different Figures may be identified by the use of similar digits. For example, 110 may reference element “10” in FIG. 1, and a similar element may be referenced as 210 in FIG. 2. As will be appreciated, elements shown in the various embodiments herein can be added, exchanged, and/or eliminated so as to provide any number of additional embodiments of the filter system. In addition, the elements shown in the various embodiments are not necessarily to scale.
  • Various embodiments of the invention are illustrated in the figures. Generally, the filter system can be used to provide a temporary valve for replacement or repair of a diseased and/or damaged valve. Other embodiments can be used to provide a temporary valve and filter during a procedure to repair a diseased or damaged valve or replace a diseased and/or damaged valve with a permanent valve. For example, the placement of the valve and filter apparatus within a body lumen (e.g., within the aorta, adjacent the aortic valve), can help to provide for a temporary valve and filter to regulate fluid flow and filter particulate matter from fluid flowing through the aorta during transluminal cardiac valve repair and/or replacement.
  • FIGS. 1A and 1B illustrate one embodiment of a filter system 100 shown in perspective view. Filter system 100 includes an elongate filter body 102 including an expandable filter region 150 and a valve 104. FIGS. 1A and 1B provide a perspective illustration of the valve 104 of filter system 100 in an open configuration (FIG. 1A) and a closed configuration (FIG. 1B). In addition, the perspectives illustrated in FIGS. 1A and 1B show the filter system 100 in an expanded configuration, as will be discussed herein.
  • In the present embodiments, the elongate filter body 102 defines a lumen 106 extending from a proximal end 108 towards a distal end 110. In one embodiment, the lumen 106 can be concentric with an elongate axis of the elongate filter body 102. The valve 104 also defines a lumen 112. In one example, the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body, where the lumen 112 of the valve 104 and the lumen 106 of the elongate filter body 102 can form a single lumen 114. In other words, the lumens 106 and 112 can be contiguous so as to form the single lumen 114. Other configurations are also possible.
  • In the various embodiments, filter system 100 allows for both unidirectional flow of fluid and filtering of the fluid passing through the lumens 106 and 112. With respect to providing unidirectional flow of the fluid through lumens 106 and 112, the valve 104 includes a reversibly sealable opening 116. In one embodiment, the reversibly sealable opening 116 can be formed by one or more valve leaflets 118. In forming the reversibly sealable opening 116, the valve leaflets 118 are configured to move between an open configuration (e.g., FIG. 1A, allowing fluid to flow in a first direction 193 through the lumens 106 and 112) and a closed configuration (e.g., FIG. 1B, preventing fluid from flowing in a second direction 197 opposite the first direction 193).
  • The valve 104 can include any number of configurations so as to define the lumen 112 and provide the reversibly sealable opening 116 for unidirectional flow of the fluid through the lumen 112. For example, the valve 104 can include a frame 120 that supports a cover 122. In the various embodiments, the cover 122 defines the reversibly sealable valve leaflets 118 that provide for the unidirectional flow of a fluid through the lumen 112 of the valve 104.
  • Examples of a valve suitable for use as valve 104 is illustrated in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0020001, BSCI Docket No. 03-340US), and in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0120001, BSCI Docket No. 04-0080US), both of which are hereby incorporated by reference in their entirety. As illustrated, frame 120 includes a variety of structural configurations. Generally, the frame 120 has a curved structural configuration, as will be discussed herein. For example, the frame 120 can include a first elliptical member 124 and a second elliptical member 126, as illustrated in FIGS. 1A and 1B.
  • In the various embodiments, the first elliptical member 124 and the second elliptical member 126 meet at a first region 128 and a second region 130, where the first region 128 and the second region 130 are opposite each other across axis 132. The first region 128 and the second region 130 can be located at any number of locations along the first elliptical member 124 and the second elliptical member 126. For example, the first region 128 and the second region 130 can be at or near a minor axis of the first elliptical member 124 and the second elliptical member 126. In an additional embodiment, the first region 128 and the second region 130 can be positioned away from the minor axis of the first elliptical member 124 and the second elliptical member 126.
  • While the term elliptical member is used herein, other shapes are possible for the structural members that help to form a valve according to the embodiments herein. For example, the frame 120 can include circular members that meet at the first region 128 and the second region 130. Other shapes besides elliptical and circular are also possible.
  • The first elliptical member 124 and the second elliptical member 126 meet at the first region 128 and the second region 130 at an angle 134. In one embodiment, the size of angle 134 when the valve 104 is expanded can be selected based upon the type of body lumen and the body lumen size in which the valve 104 is to be placed. Additional factors include, but are not limited to, a longitudinal length 136 and a width 138 of the valve 104. These factors, along with others discussed herein, can be used to provide the angle 134 that is sufficient to ensure that the first elliptical member 124 and the second elliptical member 126 have an appropriate expansion force against an inner wall of the body lumen in which the valve 104 is being placed.
  • The valve 104 also includes a flexible joint at and/or around axis 132 that allows the valve 104 to accommodate changes in body lumen size (e.g., diameter of the body lumen) by increasing or decreasing angle 134 when the valve 104 is expanded. In addition, the frame 120 also has the ability to flex, as discussed herein, to allow for the distance between the first region 128 and the second region 130 to increase or decrease, thereby further accommodating changes in the body lumen size (e.g., diameter of the body lumen). The frame 120 also provides sufficient contact and expansion force with the surface of a body lumen wall to encourage seating of the valve 104 and to prevent retrograde flow, i.e., second direction 197, within the body lumen.
  • The frame 120 can be formed from a biocompatible metal, metal alloy, polymeric material, or combinations thereof, which allow the frame 120 to move radially between the collapsed and expanded state, as discussed herein. To accomplish this, the biocompatible metal, metal alloy, or polymeric material should exhibit a low elastic modulus and a high yield stress for large elastic strains that can recover from elastic deformations. Examples of suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. In an additional embodiment, the frame 120 may be formed from a shape-memory material. Examples of a suitable shape-memory material include, but are not limited to, alloys of nickel and titanium in specific proportions known in the art as nitinol. Other materials are also possible.
  • The valve 104 can further include one or more radiopaque markers 152 (e.g., tabs, sleeves, welds). For example, one or more portions of the frame 120 can be formed from a radiopaque material. Radiopaque markers can be attached to and/or coated onto one or more locations along the frame 120. Examples of radiopaque materials include, but are not limited to, gold, tantalum, and platinum. The position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of the valve 104 during its implantation.
  • The valve 104 further includes the cover 122. In the various embodiments, the cover 122 forms the valve leaflets 118 joined to valve frame 120. The valve leaflets 118 can deflect between a closed configuration (FIG. 1B) in which retrograde fluid flow through the valve 104 is restricted, and an open configuration (FIG. 1A) in which antegrade fluid flow through the valve 104 is permitted. In one embodiment, valve leaflets 118 of the valve are configured to open and close in response to the fluid motion and/or pressure differential across the valve leaflets 118.
  • The example of valve 104 shown in FIGS. 1A and 1B provide embodiments in which the surfaces defining the reversibly sealable opening 116 include a first leaflet 140 and a second leaflet 142 coupled to the valve frame 120 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 104. Although the embodiments illustrated in FIGS. 1A-1B of the present invention show and describe a two-leaflet configuration for valve 104, designs employing a different number of valve leaflets (e.g., tricuspid valve) are possible and considered within the scope of the embodiments.
  • The valve leaflets 118 can have a variety of sizes and shapes. For example, each of the valve leaflets 118 (e.g., first leaflet 140 and second leaflet 142) can have a similar size and shape. In an additional example, each of the valve leaflets 118 need not have valve leaflets 118 that are of a similar size and shape (i.e., the valve leaflets can have a different size and shape).
  • Valve frame 120 can include an open frame construction (i.e., valve frame 120 defines an opening) through which valve leaflets 118 can radially-collapse and radially-expand. The valve leaflets 118 can be provided over the open frame construction of the valve frame 120 to direct fluid flow through reversibly sealable opening 116 under specific fluid flow conditions. In one embodiment, the material of the valve leaflets 118 coupled to the valve frame 120 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets 118 for delivery by catheter to a location within a body lumen.
  • In one embodiment, each of the valve leaflets 118 includes sufficient excess material spanning valve frame 120 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 118 forces the valve 104 into an open configuration (FIG. 1A). Valve leaflets 118 can further include arcuate edges 144 and 146, as shown in FIG. 1A, that are positioned adjacent each other along a substantially catenary curve between the first region 128 and the second region 130 in the closed configuration (FIG. 1B) of valve 104. Similarly, arcuate edges 144 and 146 can help to define lumen 112 when the valve 104 is in the open configuration (FIG. 1A).
  • In an additional embodiment, in the open configuration the sufficient excess material spanning the valve frame 120 can allow the valve leaflets 118 to take on a semi-tubular structure, as shown in FIG. 1A, when fluid pressure opens the valve 104. In an additional embodiment, arcuate edge 144 and 146 of valve 100 can open to approximately the full inner diameter of body lumen.
  • Each of the valve leaflets 118 can further include a curve imparted thereto so as to provide a concave structure 148 to the leaflet 118. The concave structure 148 allows the valve leaflets 118 to better collect retrograde fluid flow to urge valve leaflets 118 towards the closed configuration. For example, as retrograde flow begins, the valve leaflets 118 respond by moving towards the center of valve 104. As the valve leaflets 118 approach the center of the device the valve leaflets 118 make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow.
  • In an additional embodiment, the valve leaflets 118 can include one or more support structures. For example, the valve leaflets 118 can include one or more support ribs having a predetermined shape. In one embodiment, the predetermined shape of the support ribs can include a curved bias so as to provide the valve leaflets 118 with a curved configuration. Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible when valve leaflets 118 are urged into an open position, and stiff when the valve leaflets 118 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve. In an additional embodiment, support ribs can also be attached to valve frame 120 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration.
  • The valve leaflets 118 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic. Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like. Possible biologic materials include, but are not limited to allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein.
  • Valve leaflets 118 can be coupled to the various embodiments of valve frame 120, as described herein, in any number of ways. For example, a variety of fasteners can be used to couple the material of the valve leaflets 118 to the valve frame 120. Fasteners can include, but are not limited to, biocompatible staples, glues, and sutures. In one embodiment, the material of the valve leaflets 118 can be wrapped at least partially around the valve frame 120 and coupled using the fastener. In an additional embodiment, valve leaflets 118 can be coupled to the various embodiments of valve frame 120 through the use of heat sealing, solvent bonding, adhesive bonding, or welding the valve leaflets 118 to either a portion of the valve leaflet 118 (i.e., itself) and/or the valve frame 120. Valve leaflets 118 can also be attached to valve frame 120 according to the methods described in U.S. Patent Application Publication US 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety.
  • In an alternative embodiment, the valve 104 can include three leaflets, with the various frames and covering configurations as described herein. Further, valve 104 can be configured to extend proximally and distally in a curvilinear manner to accommodate the coronary ostia and the diseased valve. For example, leaflets can extend past the coronary ostia in the central portion of the leaflets, and extend to accommodate the attachment points of the diseased valve by incorporating a tri-lobar saddle shaped configuration. In one embodiment, the valve 104 can include a configuration that allows the valve 104 to be place functionally distal to the coronary ostia for proper coronary perfusion, while maintaining sufficient clearance for the diseased valve and the repair or replacement of the diseased valve to be performed. Examples of a three leaflet valve suitable for use as valve 104 are illustrated in U.S. patent application Ser. No. ______, entitled “Valve Apparatus, System and Method” (BSCI Atty Docket No. 04-0223US and B&C Atty. Docket No. 201.0170001), and U.S. patent application Ser. No. ______, entitled “Cardiac Valve, System, and Method” (BSCI Atty Docket No. 03-487US and B&C Atty Docket No. 201.0070001), which is hereby incorporated by reference in its entirety.
  • In various embodiments, a portion of the elongate filter body 102 can include an expandable filter region 150 to filter the unidirectional flow of the fluid moving through the valve 104. As used herein, filtering of fluid can be accomplished through use of the expandable filter region 150 by trapping and/or inhibiting the passage of particular matter released into and/or present in the fluid moving through the valve 104. Trapped particulate matter can then be removed with the filter system 100 through the lumen 106.
  • As illustrated in FIGS. 1A-1B, the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body 102. For example, the frame 120 of the valve 104 can be coupled to the expandable filter region 150 proximal the distal end 110 of the elongate filter body 102. Methods of coupling the frame 120 to the expandable filter region 150 of the elongate filter body 102 can be as described herein for coupling the valve leaflets 118 to the frame 120.
  • As will be illustrated herein, the expandable filter region 150 can move between a first configuration (e.g., a compressed state, shown in FIG. 3A) and a second configuration (e.g., an expanded state, shown in FIGS. 1A-1B and FIGS. 2A-2B). In one embodiment, the expandable filter region 150 can expand from the first configuration to the second configuration due to force imparted by the frame 120 as it expands. In addition, the expandable filter region 150 can expand from the first configuration to the second configuration by a combination of force imparted by the frame 120 as it expands and under pressure of the unidirectional flow of the fluid. Additionally, the force imparted by the frame when the valve is in the open configuration can help to maintain the expandable filter region expanded when under retrograde fluid flow, such as when the valve is in a closed configuration. In an additional embodiment, the expandable filter region 150 can be configured to radially self-expand when released from a compressed state.
  • In the various embodiments, the expandable filter region 150 in its deployed state can fill the cross-section area of the lumen in which the expandable filter region 150 and valve 104 are deployed. In addition, filter region 150 in its deployed state can apply sufficient pressure to the inner wall of the lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 150 and the surface of the lumen wall. In one embodiment, the valve frame 120 can be used at least in part to apply the sufficient pressure to the inner wall of the body lumen. As will be appreciated, the area and shape defined by the expandable filter region 150 (e.g., the diameter of the expandable filter region) in its deployed state can be dependent upon the location in which the apparatus is intended to be used.
  • Examples of expandable filter region 150 include those having a woven, braided and/or a knit configuration as the same will be known and understood by one of ordinary skill in the art. Alternatively, the expandable filter regions 150 can be formed of a material having pores formed therein or imparted thereto. In the various embodiments, the expandable filter regions 150 can be formed of a number of materials. Materials can include polymers, such as ePTFE, PTFE, polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, PE, PET, silk, urethane, Rayon, Silicone, polyamid, mixtures, and block co-polymers thereof.
  • In one embodiment, expandable filter region 150 can be configured to reduce passage of potentially injurious emboli to arteries feeding the brain, heart, kidneys, and other tissues and organs. For example, expandable filter region 150 can help to reduce or prevent passage of emboli greater than about 5 to 1000 micrometers in cross-sectional size. Expandable filter region 150 may also prevent passage of emboli larger than 50 to 200 micrometers in cross-sectional size. Multiple regions or layers of expandable filter region 150 may be incorporated to more efficiently filter emboli, such as a 200 micrometer portion of the expandable filter region 150 to capture larger particles and a 75 micrometer portion of the expandable filter region 150 to capture smaller particles.
  • Additional examples of the expandable filter region 150 include the radially self-expanding configurations formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range. Examples of such materials include, but are not limited to, nitinol and nitinol-type metal alloys. Alternatively, self-expanding configurations for the expandable filter region 150 include those having a spring-bias imparted into the members forming the filter region 150. The expandable filter region 150 can have a woven, braided and/or a knit configuration that can also impart a self-expanding aspect to the expandable filter region 150.
  • In an additional embodiment, the filter region 150 can further include radiopaque markers 152. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of the valve 104 and/or the expandable filter region 150. Other portions of filter system 100 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the filter system 100.
  • The elongate filter body 102 can further include a fluid tight plug 154 positioned within the lumen 106 of the elongate filter body 102. In one embodiment, the fluid tight plug 154 can be positioned proximal the expandable filter region 150 so as to occlude the lumen 106, thereby directing the unidirectional flow of the fluid from the lumen 106 through the expandable filter region 150.
  • The fluid tight plug 154 can have a variety of shapes and configurations. For example, a first end 155 and a second end 157 of the fluid tight plug 154 can include a flat planar surface. In an alternative embodiment, the first end 155 of the fluid tight plug can include a conical configuration, as shown in FIGS. 1A and 1B. Other shapes and configurations for the fluid tight plug 154 are also possible.
  • FIGS. 2A and 2B illustrate an additional embodiment of a filter system 200. FIGS. 2A and 2B provide a perspective illustration of the filter system 200 that includes both the elongate filter body 202, as described herein, and the valve 204. In the present example, however, the valve 204 includes a frame 220 and a cover 222, including valve leaflets 240 and 242 (shown in FIG. 2A), having a different configuration as compared to the valve 104 described above in FIGS. 1A and 1B. One example of valve 204 is illustrated in U.S. patent application Ser. No. ______, entitled “Venous Valve Apparatus, System, and Method” (B&C Docket No. 201.0010001, BSCI Docket No. 03-341US), which is hereby incorporated by reference in its entirety.
  • The frame 220 of valve 204 includes an outer surface 256 and an inner surface 258 opposite the outer surface 256. The inner surface 258 defines the lumen 212 of the valve 204 for passing fluid therethrough. The frame 220 also includes a first end 262 and a second end 260. In one embodiment, the cover 222 can be located over at least the outer surface 256 of the frame 220. For example, the cover 222 can extend around a perimeter of the frame 220 so as to completely cover the outer surface 256 of the frame 220. In other words, the cover 222 extends over the outer surface of the frame 220 so that there are no exposed portions of the outer surface 256 of the frame 220. In an additional embodiment, the cover 222 can also be located over at least the inner surface 258 of the frame 220. A further embodiment includes the cover 222 located over at least the outer surface 256 and the inner surface 258.
  • In one embodiment, the frame 220 can include an open frame configuration that includes a first vertex 263 and a second vertex 264 relative the second end 260 of the frame 220. Frame 220 can further include a first valley 266 and a second valley 268 adjacent the second end 260 relative the first vertex 263 and the second vertex 264. As illustrated in FIGS. 2A and 2B, the first vertex 263 and the second vertex 264 can be positioned opposite each other along a common axis 270 (shown in FIG. 2B). FIGS. 2A and 2B also illustrate that the first valley 266 and the second valley 268 can be positioned opposite each other and perpendicular to axis 270. Other relative positions for the first and second vertex 263 and 264, and the first and second valley 266 and 268 are also possible. As one of ordinary skill will understand, more than two vertexes and valleys may be included in the embodiments. For example, where an embodiment includes three valve leaflets, e.g., a tricuspid valve, three vertexes and three valleys can also be included to help form the three leaflets.
  • The cover 222 can further include valve leaflets 240 and 242 that define the reversibly sealable opening 216 for the unidirectional flow of the fluid through the lumen 212. For example, the surfaces of the cover 222 can be deflectable between a closed configuration (FIG. 2B) in which fluid flow through the lumen 212 can be restricted and an open configuration (FIG. 2A) in which fluid flow through the lumen 212 can be permitted in response to the fluid motion and/or pressure differential across the valve leaflets 240 and 242.
  • The example of valve 204 shown in FIGS. 2A and 2B provide embodiments in which the surfaces defining the reversibly sealable opening 216 include the first leaflet 240 and the second leaflet 242 coupled to the valve frame 220 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 204. Although the embodiments illustrated in FIGS. 2A and 2B of the present invention show and describe a two-leaflet configuration for valve 204, designs employing a different number of valve leaflets (e.g., tricuspid valve) are also possible.
  • In one embodiment, each of the valve leaflets 240 and 242 include sufficient excess material spanning valve frame 220 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 240 and 242 forces the valve 204 into an open configuration (FIG. 2A). Valve leaflets 240 and 242 further include arcuate edges, as illustrated in FIGS. 1A and 1B and shown as 144 and 146, that are positioned adjacent each other along a substantially catenary curve between the first vertex 263 and the second vertex 264 in the closed configuration (Figure B) of valve 204. Similarly, arcuate edges 244 and 246 can help to define lumen 212 when the valve 204 is in the open configuration (FIG. 2A).
  • In an additional embodiment, in the open configuration the sufficient excess material spanning the valve frame 220 between the first vertex 263 and the second vertex 264 can allow the valve leaflets 240 and 242 to take on a semi-tubular structure, as shown in FIG. 2A, when fluid pressure opens the valve 204. In an additional embodiment, arcuate edge 244 and 246 of valve 204 can open to approximately the full inner diameter of body lumen.
  • Each of the valve leaflets 240 and 242 can further include a curve imparted thereto so as to provide a concave structure to the leaflet 240 and 242. The concave structure allows the valve leaflets 240 and 242 to better collect retrograde fluid flow to urge valve leaflets 240 and 242 towards the closed configuration (FIG. 2B). For example, as retrograde flow begins, the valve leaflets 240 and 242 respond by moving towards the center of valve 204. As the valve leaflets 240 and 242 approach the center of the device the valve leaflets 240 and 242 can make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow, i.e., second direction 197 as shown in FIGS. 1A and 1B.
  • FIGS. 3A and 3B provide a further illustration of the filter system 300 (i.e., the elongate filter body 302, valve 304, and filter region 350) that includes a sheath 374 having a lumen 376. FIGS. 3A and 3B provide a sectional illustration of the filter system 300 at least partially contained within a lumen 376 of the sheath 374 (FIG. 3A) and of the filter system 300 at least partially deployed from the lumen 376 of the sheath 374 (FIG. 3B).
  • In various embodiments, both the valve 304 and the filter region 350 of the elongate filter body 302 can be releasably positioned in a coaxial arrangement within the lumen 376 of the sheath 374. As discussed herein, the configuration of the support frame 320 provides the valve 304 with sufficient flexibility to move between the first configuration 342 (e.g., a retracted state within the lumen 376 of the sheath 374 as shown in FIG. 3A) and the second configuration 344 (e.g., an extended state outside the lumen 376 of the sheath 374 as shown in Figures FIG. 3B).
  • In one embodiment, the valve 304 can be configured to reside in the compressed state when retracted within the lumen 376 of the sheath 374, as illustrated in FIG. 3A, and in an expanded state when extended from the lumen 376 of the sheath 374, as illustrated in FIG. 3B. In one embodiment, the valve 304 expands from its compressed state within the lumen 376 to the deployed state when the sheath 374 is retracted from around the valve 304.
  • The sheath 374 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, the sheath 374 can have a wall thickness and an inner diameter sufficient to maintain both the valve 304 and the expandable filter region 350 in the retracted state when they are positioned within the lumen 376. In an additional embodiment, the sheath 374 can further include radiopaque markers 352. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location and allow for visualization of the location and position of parts of the sheath 374.
  • In the various embodiments, the support frame 320 of the cardiac valve 304 expands to increase the diameter 312 of the lumen 306 of the valve 304 as the valve 304 is extended from the sheath 374. In one embodiment, the diameter 312 of the lumen 306 can be determined based upon the type of body lumen and the body lumen size in which the valve 304 is to be placed. In an additional example, there can also be a minimum value for the width for the support frame 320 that ensures that the valve 304 will have an appropriate expansion force against the inner wall of the body lumen to prevent retrograde flow within the body lumen.
  • In addition, the lumen 306 of the elongate filter body 302 in the filter region 350 also increases in diameter as the valve 304 and the elongate filter body 302 are extended from the sheath 374. In one embodiment, the expandable filter region 350 can expand from the first configuration to the second configuration due in part to force imparted by the frame 320 as it expands and under pressure of the unidirectional flow of the fluid. In an additional embodiment, the expandable filter region 350 can be configured to radially self-expand, as the same has been described herein, when released from its compressed state within the lumen 376 of the sheath 374.
  • The expandable filter region 350 in its deployed state can fill the cross-section area of a body lumen in which the valve 304 and expandable filter region 350 are deployed. In addition, filter region 350 in its deployed state can apply sufficient pressure to the inner wall of the body lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 350 and the surface of the body lumen wall. As will be appreciated, the area and shape defined by the expandable filter region 350 (e.g., the diameter of the expandable filter) in its deployed state will be dependent upon the location in which the filter system is intended to be used.
  • The filter system 300 can be extended and retracted from the lumen 376 of the sheath 374 in any number of ways. For example, the elongate filter body 302 can be pulled longitudinally within the lumen 376 of the sheath 374 so as to retract the valve 304 and the filter region 350 of the elongate filter body 302. In this embodiment, the elongate filter body 302, supported by the sheath 374, provides sufficient column strength to allow force imparted at the proximal end 308 of the elongate filter body 302 to retract the valve 304 and the filter region 350.
  • In an additional embodiment, a portion of the elongate filter body 302 extending from the filter region 350 to the proximal end 308 can be reinforced and/or have an alternative construction relative the filter region 350 so as to impart sufficient column strength to the elongate filter body 302. The elongate filter body 302 can then be pushed longitudinally within the lumen 376 of the sheath 374 so as to extend the valve 304 and the filter region 350 of the elongate filter body 302.
  • In an additional embodiment, the valve 304 and the filter region 350 can be deployed and retracted by moving the sheath 374 relative the elongate filter body 302. In this embodiment, the elongate filter body 302 can be held while the sheath 374 is moved longitudinally so as to either deploy or retract the valve 304 and the filter region 350.
  • The filter system 300 and the sheath 374 can further include handles positioned at the proximal end 308 of the elongate filter body 302 and a first sheath end 378 of the sheath 374. In one embodiment, the sheath 374 includes a handle 382 and the elongate filter body 302 includes a handle 384. Handles 382 and 384 allow the sheath 374 and the elongate filter body 302 to move relative to each other so as to extend and/or retract the valve and a portion of the elongate filter body from the lumen 376 of the sheath 374. In one embodiment, the distance between the handles 382 and 384 can correspond approximately to the length of the compacted valve 304 and the filter region 350 to effectively deploy the expandable filter region 350 and valve 304. Other configurations and relational lengths are possible.
  • In an additional embodiment, filter system 300 and the sheath 374 can further include a sleeve 386 having a slit 388 and a pull tab 390 positioned between the handles during delivery to prevent inadvertent exposure of the valve 304 and filter region 350. For example, the sleeve 386 can be stripped from the filter system 300 by pulling the pull tab once the sheath 374 has been placed at the predetermined location at which the valve 304 and the filter region 350 are to be deployed. Other removable structures for preventing inadvertent exposure of the valve 304 and filter region 350 are also possible.
  • In an additional embodiment, the filter system 300, as shown in FIG. 3C can be extended and/or retracted from the sheath 374 through the use of a deployment rod 394. In one embodiment, the deployment rod 394 extends from the proximal end 308 of the elongate filter body 302 through the lumen 376 to the fluid tight plug 354, as the same has been described in connection with FIGS. 1A and 1B. In one embodiment, the deployment rod 394 can be used to move the elongate filter body 302 and the valve 304 relative the sheath 374.
  • For example, the deployment rod 394 can extend through the lumen 312 to the fluid tight plug 354, where the deployment rod 394 can be used to push the filter system 300 relative the sheath 374 to deploy the valve 304 and the filter region 350 and/or pull the filter system 300 relative the sheath 374 to draw the valve 304 and the filter region 350 back into its compressed state within the lumen 376 of the sheath 374. Alternatively, the deployment rod 394 can be used to change the position of the valve 304 and filter region 350 once deployed from a first position within the lumen to a second position.
  • In the various embodiments, the deployment rod 394 and the fluid tight plug 354 can further include releasably interconnecting members to allow the deployment rod 394 and the fluid tight plug 354 to be separated. For example, the fluid tight plug 354 can include a socket having threads to receive and interact with a threaded portion of the deployment rod 394. This structure allows for the deployment rod 394 to be inserted through the lumen 376 of the elongate filter body 302 to the fluid tight plug 354, where the treaded portion of the deployment rod 394 can be screwed into the threaded socket of the fluid tight plug 354. The deployment rod 394 can then be removed from the lumen 376 by unscrewing the threaded portion of the deployment rod 394 from the threaded socket of the fluid tight plug 354. As will be appreciated, other ways of decoupling the deployment rod 394 and the fluid tight plug 354 are also possible.
  • In one embodiment, the deployment rod 394 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, the deployment rod 394 can be formed of medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.
  • FIGS. 4A-4D provides a further illustration of the filter system 400 that includes the sheath 474, as previously discussed, and a catheter 401 and an apparatus 445. FIGS. 4A-4D provide perspective illustrations of the filter system 400 at least partially contained within the lumen 476 of the sheath 474, with the catheter 401 and the apparatus 445 at least partially contained within a lumen 406 of the elongate filter body 402.
  • Examples of the catheter 401 and the apparatus 445 are illustrated in U.S. patent application Ser. No. ______, entitled “Vascular Catheter, System, and Method” (B&C Docket No. 201.0080001, BSCI Docket No. 03-498US), which is hereby incorporated by reference in its entirety. In the various embodiments, the catheter 401 includes an elongate body 403 having a first lumen 405 extending between a proximal end 407 and a distal end 409. In one embodiment, the first lumen 405 allows for additional elongate members to travel along a longitudinal axis of the elongate body 402.
  • The catheter 401 further includes a first cutting head 411 having a blade 413 and an elongate pulling member 415. The first cutting head 411 can be positioned adjacent the distal end 409 of the elongate body 403 of the catheter 401 with the elongate pulling member 415 extending through the first lumen 405. In one embodiment, the elongate pulling member 415 can slide within the first lumen 405 to move the first cutting head 411 relative the distal end 409 of the elongate body 403 of the catheter 401.
  • The catheter 401 also includes a second cutting head 417 having a blade 419. The second cutting head 417 can be positioned adjacent the distal end 409 of the elongate body 403 between the distal end 409 and the first cutting head 411. The blade 413 of the first cutting head 411 can move relative the blade 419 of the second cutting head 417 to provide a shearing action. In one example, the shearing action can be sufficient for cutting cardiac tissue.
  • FIG. 4A further illustrates an embodiment in which the second cutting head includes an elongate pushing member 421. In one embodiment, the elongate pushing member 421 can slide within the first lumen 405 to move the second cutting head 417 relative the distal end 409 of the elongate body 403 and the first cutting head 411. In one embodiment, the elongate pulling member 415 can be arranged concentrically with the elongate pushing member 421 in the first lumen 405.
  • As illustrated, the elongate pulling member 415, the elongate pushing member 421 and the first lumen 405 of the elongate body 403 can be positioned coaxially. In one embodiment, the lumen 405 has a diameter sufficient to accommodate the elongate pushing member 421. Similarly, the elongate pushing member 421 had a diameter sufficient to accommodate the elongate pulling member 415.
  • In addition, the elongate pulling member 415 and the elongate pushing member 421 can be structured such that their relative rotational movement is restricted. In other words, relative axial rotation of the elongate pulling member 415 and the elongate pushing member 421 is restricted due to the structure of the members 415 and 421. For example, this can be accomplished using one or more physical structures formed in and/or attached to the members 415 and 421. In one embodiment, one of the members 415 or 421 can include a channel through which an extension from the other of the members 415 or 421 can travel so as to inhibit axial rotation of the members 415 and 421. Alternatively, the members 415 and 421 could have a cross-sectional shape that inhibits relative axial rotation. Examples of such cross-sectional shapes include oval or elliptical cross-sectional shapes. Other shapes are also possible.
  • In addition to providing a sufficient diameter, a gap can exist between the opposing surfaces of the first lumen 405 and the elongate pushing member 421 to allow the elongate pushing member 421 to move through the first lumen 405 from force applied at the proximal end of the elongate pushing member 421. Similarly, a gap can exist between the opposing surfaces of the elongate pushing member 421 and the elongate pulling member 415 to allow the elongate pushing member 421 and the elongate pulling member 415 to move relative each other from force applied at the proximal end of the elongate pushing member 421 and/or the elongate pulling member 415. The elongate pull member 415 can further include a lumen 471 for tracking over a guidewire. A lubricant can be included on the surfaces of the elongate pulling member 415, the elongate pushing member 421 and the first lumen 405.
  • The first cutting head 411 further includes a shape conducive to passing the catheter 401 and the filter system 400 through a body lumen (e.g., a lumen of the cardiovascular system). For example, the first cutting head 411 can include a conical shape having a first end 423 and a second end 425, where the first end 423 has a diameter that is less than a diameter of the second end 425. Other shapes are also possible. In addition, the shape of the first cutting head 411 can be configured to protectively house the blade 413 from structures passing by the first end 423 towards the second end 425. In other words, the shape of the first cutting head 411 can be used to shield the blade 413 from unintentionally interfering and/or cutting tissue within a body lumen.
  • In one embodiment, the blade 413 can be radially positioned relative the elongate pulling member 415 generally along the second end 425 of the first cutting head 411. As will be appreciated, the first cutting head 411 can include more than one blade 413. Each blade 413 and 419 further includes a cutting edge 427 and 429, respectively, in alignment so as to provide shearing action between a pair of the cutting edges 427 and 429 of the blades 413 and 419. For example, the first cutting head 411 can move relative the second cutting head 417 to allow the cutting edge 427 of the blade 413 of the first cutting head 411 to slide past the cutting edge 429 of the blade 417 of the second cutting head 417. Example of suitable materials for the blades 413 and 419 include, but are not limited to, stainless steel (e.g., 316L) and titanium.
  • In one embodiment, blades 413 and 419 can be secured to the first cutting head 411 and the second cutting head 417, respectively, in any number of ways. For example, blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of mechanical fasteners, such as screws, and/or interlocking pins and sockets. In addition, blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of chemical adhesives. Examples of such chemical adhesives include, but are not limited to, medical grade adhesives such as cyanoacrylate, acrylic, silicone, and urethane adhesives.
  • In an additional embodiment, the first cutting head 411 can be configured to receive and house at least a portion of the second cutting head 417, including the blade 419, such that the second blade 419 does not pass beyond the first cutting head 411. For example, the first cutting head can include a socket that extends radially relative the elongate pulling member 415 and distally from the blade 413 to receive the blade 419 of the second cutting head 417 as the blade 419 passes the blade 413. In one embodiment, the blade 419 can be positioned within the socket of the first cutting head 411 as the catheter 401 is moved through a lumen.
  • Catheter 401 can have various lengths between the proximal end 407 and the first cutting head 411. In one embodiment, the length between the proximal end 407 and the first cutting head 411 is sufficient to allow the catheter 401 to be percutaneously implanted through a patient's vasculature to position the cutting heads (e.g., the first and second cutting heads) at a predetermined location. Examples of the predetermined locations include, but are not limited to, cardiovascular locations such as on or adjacent to a cardiac valve of the heart (e.g., the aortic valve), including within a chamber of the patient's heart (e.g., the left ventricle of the heart). As will be appreciated, the length between the proximal end 407 and the first cutting head 411 will be dependent upon each patient's physiological structure and the predetermined location within the patient.
  • The elongate body 403 of the catheter 401, the elongate pulling member 415, the elongate pushing member 421, the second cutting head 417 and the first cutting head 411 can be formed from a wide variety of materials and in a wide variety of configurations. For example, the materials may include, but are not limited to, one or more of polyvinyl chloride (PVC), polyethylene (PE), polyolefin copolymer (POC), polyethylene terephthalate (PET), polyamid, mixtures, and block co-polymers thereof. Alternatively, the materials may include one or more alloys in any number of configurations. For example, the materials may include stainless steel (e.g., 316L), titanium, or other medical grade alloys as are known. These materials may also have a woven configuration or a solid extruded configuration.
  • The selection of material and configuration allows for the elongate body 403, the elongate pulling member 415, the elongate pushing member 421, the second cutting head 417 and the first cutting head 411 to each have the flexibility, and the ability to be either pushed and/or pulled thereby accomplishing the actions described for the components herein. As will be appreciated, selection of the material can be based generally on a broad range of technical properties, including, but not limited to, modulus of elasticity, flexural modulus, and Shore A hardness required for the embodiments of the present invention. Components of the present apparatus and/or system can also be coated for lubrication, for abrasion resistance, or to deliver an anticoagulatory drug.
  • As an alternative configuration, the cutting mechanism of first cutting head 411 and second cutting head 417 can be accomplished by alternate cutting, shearing, slicing, grinding or ablative means as are known for other purposes. For example, thermal energy can be used to weaken or slice the diseased valve, rolling cutters could be incorporated, or a “cutting balloon” mechanism could be incorporated.
  • In an additional embodiment, the catheter 401 can further include radiopaque markers 431. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of the first cutting head 411 and the second cutting head 417. In addition, radiopaque markers can be used to mark the location of blades 413 and 419. Other portions of catheter 401 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the catheter 401.
  • As illustrated in FIG. 4A, catheter 401 can reside at least partially within the lumen 406 of the elongate filter body. FIG. 4B provides an example in which both the valve 404 and the filter region 450 have been extended from the sheath 474, as discussed herein, with the catheter 401 at least partially extending distally from the valve 404. In the various embodiments, the valve leaflets of valve 404 can seat around the elongate body 403 of the catheter 401 to provide the reversibly sealable opening of the valve 404.
  • In the various embodiments, the elongate body 403 can travel longitudinally within the lumen 406 of the elongate filter body 402 to extend and retract the distal end 409 of the catheter 401 relative the valve 404 of the filter system 400. The elongate filter body 402 can further include a sealing ring that allows the elongate body 403 of the catheter 401 to move longitudinally while maintaining a fluid tight seal within the lumen 406 of the elongate filter body 402.
  • In addition to the structures described herein, the elongate body 403 of catheter 401 further includes a second lumen 435, as shown in FIG. 4A. In one embodiment, the second lumen 435 can extend between the proximal end 407 and the distal end 409 of the elongate body 403, where the second lumen 435 can be coupled in fluid tight communication to an inflatable balloon 437 on the elongate body 403. The catheter 401 can further include an inflation device 495 that can reversibly couple in fluid tight communication with the second lumen 435 to provide fluid pressure to inflate and deflate balloon 437.
  • In one embodiment, the inflatable balloon 437 can be positioned adjacent the distal end 409 of the elongate body 403 and proximal to the second cutting head 417. The inflatable balloon 437 can be inflated from a deflated state to an inflated state by pressure applied by fluid moving through the second lumen 435. In addition, the catheter 401 further includes an expandable stent 439 positioned over at least a portion of the inflatable balloon 437. The expandable stent 439 can move between a compressed state, as shown in FIG. 4B, and an expanded state, as shown in FIG. 4C, using the inflatable balloon 437. In one embodiment, the expandable stent 439 can be deployed over cardiac tissue sheared using the first and second cutting heads 411 and 417 using the inflatable balloon 437.
  • Catheter 401 can further include an annular push ring 441 positioned between the second cutting head 417 and the inflatable balloon 437. The annular push ring 441 can be used for contacting and moving at least a portion of cardiac tissue sheared with the first and second cutting heads 411 and 417. For example, the first and second cutting heads 411 and 417 can be used to shear cardiac tissue (e.g., one or more cusps of a valve). The annular push ring 441 can then be advanced into contact with the sheared cardiac tissue. As the annular push ring 441 advances the sheared cardiac tissue can be directed towards the wall of the lumen. Stent 439 can then be positioned over at least a portion of the sheared cardiac tissue positioned using the annular push ring 441. Stent 439 can then be deployed using the inflatable balloon 437 to position at least a portion of the sheared cardiac tissue between the expanded stent 439 and the wall of the lumen. As will be appreciated, the dimensions and physical characteristics of the stent 439 will be dependent upon the location in which the stent 439 is to be implanted.
  • The apparatus 445 can further include a cardiac valve 455. The cardiac valve 455 can be releasably positioned adjacent the expandable stent 439 over at least a portion of the inflatable balloon 437. Generally, cardiac valve 455 can be implanted within the fluid passageway of a body lumen, such as for replacement of a valve structure within the body lumen to regulate the flow of a bodily fluid through the body lumen in a single direction.
  • With respect to the apparatus 445, the cardiac valve 455 can be configured to reside in a compressed state over at least a portion of the inflatable balloon 437. Using the inflatable balloon, the cardiac valve 455 can be expanded into a deployed state as illustrated in FIGS. 4C and 4D.
  • One example of cardiac valve 455 includes valve 204 as described herein. An additional embodiment of cardiac valve 455 is illustrated in U.S. patent application Ser. No. ______, entitled “Vascular Catheter, System, and Method” (B&C Docket No. 201.0080001, BSCI Docket No. 03-498US), which is hereby incorporated by reference in its entirety.
  • Generally, the cardiac valve 455 includes a support frame and a cover. The cover of the cardiac valve 455 can be positioned over at least the outer surface of the support frame. In one embodiment, the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of the cardiac valve 455.
  • The filter system 400, catheter 401 and the apparatus 445 can further include handles to allow the various components to be moved relative each other. For example, handles 479 can allow the elongate pushing member 421 and/or the elongate pulling member 415 to be moved relative each other. Handle 481 can allow the catheter 401 to be moved relative the apparatus 445 and the sheath 474. In addition, handles 483 can allow the sheath 474 and the filter system 400 to be moved relative each other. As will be appreciated, other structures may be used in place of or in addition to the handles to allow the various components of the filter system 400, catheter 401, and apparatus 445 to move relative each other.
  • The embodiments of the present invention further include methods for forming the filter system and apparatus, as discussed herein. For example, embodiments of the present invention can be formed by providing an elongate filter body that includes the expandable filter region defining a lumen. The valve can further be provided, where the valve can be adjoined proximal the distal end of the elongate filter body to form a single lumen through which fluid flows unidirectionally through the valve and the elongate filter body to filter the fluid. As provided herein, the valve can define a reversibly sealable opening for the unidirectional flow of fluid through the lumen of the valve.
  • In one embodiment, the expandable filter region can be configured to move between a first configuration and a second configuration. In one embodiment, the movement from the first configuration to the second configuration can occur as the valve expands in addition to under pressure of the unidirectional flow of the fluid. The elongate filter body can also be provided with the fluid tight plug to direct the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid. In these embodiments, the fluid tight plug can include various shapes and sizes and can be positioned according to the embodiments described herein.
  • In various embodiments, the valve can be provided with a support frame having various configurations. A first configuration can include a compressed configuration and a second configuration can include an expanded configuration. In various embodiments, expansion of the support frame can be supplemented by fluid flowing into the lumen of the elongate filter body.
  • The filter system and apparatus, as discussed herein, can further include providing the catheter having the first cutting head and the second cutting head, as discussed herein. The first cutting head can include the blade and the elongate pulling member, where the first cutting head can be positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen of the catheter. The elongate pulling member can then slides within the first lumen to move the first cutting head relative the distal end of the elongate body. The second cutting head can also include a blade, and be positioned adjacent the distal end of the elongate body between the distal end and the first cutting head. The blade of the first cutting head can be moved relative the blade of the second cutting head to provide the shearing action for cardiac tissue. The catheter extends though the lumen of the elongate filter body and the lumen of the valve.
  • In additional embodiments, the filter system and apparatus further include providing a second lumen to the elongate body, where the second lumen can be in fluid tight communication with the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head. The expandable stent can then be positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue. In further embodiment, the annular push ring can also be provided between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue. The embodiments can also include providing the cardiac valve positioned over the inflatable balloon, where the cardiac valve can be deployed through the use of the inflatable balloon.
  • While the present invention has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the spirit and scope of the invention. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the invention is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.
  • In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the invention described herein can be included within the scope of the present invention. For example, the support frame 120 and/or the cover 122 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.
  • In the foregoing Detailed Description, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the invention require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.

Claims (36)

1. A filter system, comprising:
an elongate filter body including an expandable filter region defining a lumen; and
a valve defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen, the valve adjoined the expandable filter region of the elongate filter body, wherein the expandable filter region filters the unidirectional flow of the fluid passing through the lumen of the valve and the lumen of the expandable filter region.
2. The filter system of claim 1, wherein the expandable filter region moves between a first configuration and a second configuration.
3. The filter system of claim 2, wherein the expandable filter region expands from the first configuration to the second configuration under pressure of the unidirectional flow of the fluid.
4. The filter system of claim 1, wherein the elongate filter body further includes a fluid tight plug, wherein the fluid tight plug directs the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
5. The filter system of claim 1, wherein the lumen of the valve and the lumen of the expandable filter region form a single lumen for the unidirectional flow of the fluid.
6. The filter system of claim 1, wherein the valve includes a support frame for supporting a cover, the cover including at least one valve leaflet reversibly sealable for the unidirectional flow of a fluid through the lumen of the valve.
7. The filter system of claim 6, wherein the support frame includes a first configuration and a second configuration, the first configuration being a compressed configuration and the second configuration being an expanded configuration.
8. A filter system, comprising:
an elongate filter body including an elongate filter region having a lumen; and
a valve having a lumen, the valve adjoined to the elongate filter region, wherein the lumen of the valve and the lumen of the elongate filter region form a single lumen.
9. The filter system of claim 8, wherein the valve includes a reversibly sealable opening for unidirectional flow of a fluid through the single lumen.
10. The filter system of claim 9, wherein the elongate filter region expands to filter the fluid.
11. The filter system of claim 10, wherein the expandable filter region moves between a compressed configuration and an expanded configuration.
12. The filter system of claim 11, wherein the expandable filter region expands from the compressed configuration to the expanded configuration under pressure of the unidirectional flow of the fluid.
13. The filter system of claim 12, wherein the elongate filter body further includes a fluid tight plug, wherein the fluid tight plug directs the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
14. The filter system of claim 13, wherein the fluid tight plug includes a conical region to direct the fluid from the single lumen through the expandable filter region to filter the fluid.
15. A filter system, comprising:
an elongate filter body including an expandable filter region defining a lumen;
a valve defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen of the valve, the valve adjoined to the elongate filter region, wherein the elongate filter region filters the unidirectional flow of the fluid passing through the lumen of the valve and the lumen of the elongate filter region; and
a sheath having a lumen, the valve and at least a portion of the elongate filter region reversibly positioned within the lumen of the sheath.
16. The filter system of claim 15, wherein the valve and the elongate filter region move longitudinally within the lumen of the sheath to extend and retract the valve and at least a portion of the elongate filter region.
17. The filter system of claim 16, wherein the valve and at least a portion of the elongate filter region move between a compressed configuration and an expanded configuration as the valve and the portion of the elongate filter region extend from the lumen of the sheath.
18. The filter system of claim 16, wherein the valve and at least a portion of the elongate filter region move between the expanded configuration and the compressed configuration as the valve and the portion of the elongate filter region retracts into the lumen of the sheath.
19. The filter system of claim 15, wherein the elongate filter body further includes a fluid tight plug, wherein the fluid tight plug directs the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
20. The filter system of claim 19, further including a deployment rod having a proximal and a distal end, the deployment rod extending through a portion of the lumen of the elongate filter body from a proximal end of the elongate filter body to the fluid tight plug, wherein the deployment rod moves within the lumen of the elongate filter body to extend and retract the valve and at least a portion of the elongate filter region.
21. The filter system of claim 16, further including a catheter, the catheter including:
an elongate body having a first lumen extending between a proximal end and a distal end of the elongate body;
a first cutting head having a blade and an elongate pulling member, the first cutting head positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen, wherein the elongate pulling member slides within the first lumen to move the first cutting head relative the distal end of the elongate body; and
a second cutting head having a blade, the second cutting head positioned adjacent the distal end of the elongate body between the distal end and the first cutting head, where the blade of the first cutting head moves relative the blade of the second cutting head to provide a shearing action for cardiac tissue, wherein the catheter extends through the lumen of the elongate filter body including the expandable filter region and the lumen of the valve.
22. The filter system of claim 21, wherein the elongate body further includes;
a second lumen extending between the proximal end and the distal end of the elongate body;
an inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head, the inflatable balloon in fluid tight communication with the second lumen; and
an expandable stent positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue.
23. The filter system of claim 22, further including an annular push ring positioned between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue.
24. The filter system of claim 23, further including:
a cardiac valve including a reversibly sealable opening for unidirectional flow of a liquid through a lumen of the cardiac valve, the cardiac valve releasably positioned over the inflatable balloon.
25. A system, comprising:
an elongate filter body including an expandable filter region, the elongate filter body and the expandable filter region defining a lumen and having a proximal end and a distal end;
a first cutting head having a blade and an elongate pulling member, the first cutting head positioned proximal the distal end of the elongate body with the elongate pulling member extending through a first lumen of a catheter, wherein the elongate pulling member slides within the first lumen to move the first cutting head relative the distal end of the elongate body;
a second cutting head having a blade, the second cutting head positioned adjacent the distal end of the elongate body between the distal end and the first cutting head, where the blade of the first cutting head moves relative the blade of the second cutting head to provide a shearing action for cardiac tissue, wherein the catheter extends though the lumen of the elongate filter body and the lumen of the valve;
a second lumen of a catheter extending between the proximal end and the distal end of the elongate body;
the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head, the inflatable balloon in fluid tight communication with the second lumen;
a cardiac valve including a reversibly sealable opening for unidirectional flow of a liquid through a lumen of the cardiac valve, the cardiac valve releasably positioned over the inflatable balloon; and
the expandable stent positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the cardiac valve and expandable stent over sheared cardiac tissue.
26. The system of claim 25, further including an annular push ring positioned between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue.
27. A method, comprising:
providing an elongate filter body including an expandable filter region defining a lumen;
providing a valve defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen; and
adjoining the valve to the elongate filter region to form a single lumen through which the fluid flows through the valve and the elongate filter region to filter the fluid.
28. The method of claim 27, wherein the expandable filter region filters the fluid.
29. The method of claim 28, wherein the expandable filter region moves between a first configuration and a second configuration under pressure of the unidirectional flow of the fluid, the first configuration being a compressed configuration and the second configuration being an expanded configuration.
30. The method of claim 27, wherein the elongate filter body further includes a fluid tight plug, wherein the fluid tight plug directs the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid.
31. The method of claim 27, wherein the valve includes a support frame for supporting a cover, the cover including at least one valve leaflet reversibly sealable for the unidirectional flow of a fluid through the lumen of the valve.
32. The method of claim 31, wherein the support frame includes a first configuration and a second configuration, the first configuration being a compressed configuration and the second configuration being an expanded configuration.
33. The method of claim 27, further including:
providing a catheter having an elongate body with a proximal end and a distal end and having a first lumen;
providing a first cutting head having a blade and an elongate pulling member, the first cutting head positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen, wherein the elongate pulling member slides within the first lumen to move the first cutting head relative the distal end of the elongate body; and
providing a second cutting head having a blade, the second cutting head positioned adjacent the distal end of the elongate body between the distal end and the first cutting head, where the blade of the first cutting head moves relative the blade of the second cutting head to provide a shearing action for cardiac tissue, wherein the catheter extends though the lumen of the elongate filter body and the lumen of the valve.
34. The method of claim 33, further including:
providing a second lumen extending between the proximal end and the distal end of the elongate body;
providing the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head, the inflatable balloon in fluid tight communication with the second lumen; and
providing the expandable stent positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue.
35. The method of claim 34, further including:
providing an annular push ring positioned between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue.
36. The method of claim 34, further including:
providing a cardiac valve positioned over the inflatable balloon, the cardiac valve including a reversibly sealable opening for unidirectional flow of a liquid through a lumen of the cardiac valve.
US11/049,019 2005-02-01 2005-02-01 Filter system and method Abandoned US20060173490A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US11/049,019 US20060173490A1 (en) 2005-02-01 2005-02-01 Filter system and method
EP12179239.4A EP2537486B1 (en) 2005-02-01 2006-01-06 Filter system with valve for use in valve replacement
EP06717435.9A EP1855614B1 (en) 2005-02-01 2006-01-06 Filter system with valve for use in valve replacement and method of manufacture
PCT/US2006/000230 WO2006083472A1 (en) 2005-02-01 2006-01-06 Filter system with valve for use in valve replacement and method of manufacture
CA002596296A CA2596296A1 (en) 2005-02-01 2006-01-06 Filter system with valve for use in valve replacement and method of manufacture
EP17173267.0A EP3245978A1 (en) 2005-02-01 2006-01-06 Filter system with valve for use in valve replacement
JP2007554096A JP4991572B2 (en) 2005-02-01 2006-01-06 Filter system used for valve replacement
US14/604,125 US9622859B2 (en) 2005-02-01 2015-01-23 Filter system and method
US15/257,498 US20160374793A1 (en) 2005-02-01 2016-09-06 Filter system and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/049,019 US20060173490A1 (en) 2005-02-01 2005-02-01 Filter system and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/604,125 Continuation US9622859B2 (en) 2005-02-01 2015-01-23 Filter system and method

Publications (1)

Publication Number Publication Date
US20060173490A1 true US20060173490A1 (en) 2006-08-03

Family

ID=36168792

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/049,019 Abandoned US20060173490A1 (en) 2005-02-01 2005-02-01 Filter system and method
US14/604,125 Expired - Fee Related US9622859B2 (en) 2005-02-01 2015-01-23 Filter system and method
US15/257,498 Abandoned US20160374793A1 (en) 2005-02-01 2016-09-06 Filter system and method

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/604,125 Expired - Fee Related US9622859B2 (en) 2005-02-01 2015-01-23 Filter system and method
US15/257,498 Abandoned US20160374793A1 (en) 2005-02-01 2016-09-06 Filter system and method

Country Status (5)

Country Link
US (3) US20060173490A1 (en)
EP (3) EP3245978A1 (en)
JP (1) JP4991572B2 (en)
CA (1) CA2596296A1 (en)
WO (1) WO2006083472A1 (en)

Cited By (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241735A1 (en) * 2005-04-26 2006-10-26 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device
WO2007135065A2 (en) * 2006-05-23 2007-11-29 Pah Gunnar M Apparatus for filtering blood when removing a heart valve stenosis, and method for removing a heart valve stenosis
WO2008097556A1 (en) 2007-02-05 2008-08-14 Boston Scientific Limited Systems and methods for valve delivery
WO2009068596A1 (en) * 2007-11-27 2009-06-04 Gunnar Pah Device for filtering blood
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US7854755B2 (en) * 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US20110130657A1 (en) * 2009-12-02 2011-06-02 Chomas James E Protection Device and Method Against Embolization Agent Reflux
WO2011068924A1 (en) 2009-12-02 2011-06-09 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US20120116351A1 (en) * 2009-12-02 2012-05-10 Chomas James E Method of Operating a Microvalve Protection Device
US20130096606A1 (en) * 2011-10-17 2013-04-18 William C. Bruchman Embolic protection devices and related systems and methods
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
US20130345740A1 (en) * 2012-04-30 2013-12-26 BiO2 Medical, Inc. Multi-lumen central access vena cava filter apparatus for clot management and method of using same
US20140257362A1 (en) * 2013-03-07 2014-09-11 St. Jude Medical, Cardiology Division, Inc. Filtering and removing particulates from bloodstream
US20150119977A1 (en) * 2013-10-30 2015-04-30 The Regents Of The University Of Michigan System and method to limit cerebral ischemia
US20150142102A1 (en) * 2005-02-01 2015-05-21 Boston Scientific Scimed, Inc. Filter system and method
EP2768550A4 (en) * 2011-10-19 2015-06-24 Michael Anthony T Don Apparatus and procedure for trapping embolic debris
US9089341B2 (en) 2012-02-28 2015-07-28 Surefire Medical, Inc. Renal nerve neuromodulation device
US9089668B2 (en) 2011-09-28 2015-07-28 Surefire Medical, Inc. Flow directional infusion device
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
EP2983614A4 (en) * 2013-04-12 2016-12-14 Michael Anthony T Don Apparatus and procedure for trapping embolic debris
US9598691B2 (en) 2008-04-29 2017-03-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US9757196B2 (en) 2011-09-28 2017-09-12 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9770319B2 (en) 2010-12-01 2017-09-26 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
CN107468379A (en) * 2017-09-11 2017-12-15 姜正明 A kind of aortic valve stent induction system and aortic valve systems
CN107530177A (en) * 2015-04-09 2018-01-02 弗里德曼德科技公司 For pre- anti-stroke 3D filters
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US9889031B1 (en) 2014-03-25 2018-02-13 Surefire Medical, Inc. Method of gastric artery embolization
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US9918834B2 (en) 2004-09-02 2018-03-20 Boston Scientific Scimed, Inc. Cardiac valve, system and method
US9968740B2 (en) 2014-03-25 2018-05-15 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US20180235743A1 (en) * 2017-02-23 2018-08-23 Boston Scientific Scimed, Inc. Medical drain device
US20180263752A1 (en) * 2017-03-20 2018-09-20 Surefire Medical, Inc. Dynamic Reconfigurable Microvalve Protection Device
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US20180353280A1 (en) * 2017-06-13 2018-12-13 Dai Yamanouchi Infarction prevention device and treatment method
US10154874B2 (en) 2008-04-29 2018-12-18 Virginia Tech Intellectual Properties, Inc. Immunotherapeutic methods using irreversible electroporation
GB2563880A (en) * 2017-06-28 2019-01-02 Cook Medical Technologies Llc Implantable medical device including valve member
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US10245105B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Electroporation with cooling to treat tissue
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10292755B2 (en) 2009-04-09 2019-05-21 Virginia Tech Intellectual Properties, Inc. High frequency electroporation for cancer therapy
US10471254B2 (en) 2014-05-12 2019-11-12 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US10470822B2 (en) 2008-04-29 2019-11-12 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
CN111938865A (en) * 2020-07-31 2020-11-17 李云松 Filter-related vein hyperplasia intimal cutting catheter
US11090460B2 (en) 2015-03-31 2021-08-17 Surefire Medical, Inc. Method for infusing an immunotherapy agent to a solid tumor for treatment
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11298218B2 (en) 2017-01-20 2022-04-12 W. L. Gore & Associates, Inc. Embolic filter system
US11304792B2 (en) * 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11382632B2 (en) * 2018-06-27 2022-07-12 Boston Scientific Scimed, Inc. Vascular occlusion device
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
US11453873B2 (en) 2008-04-29 2022-09-27 Virginia Tech Intellectual Properties, Inc. Methods for delivery of biphasic electrical pulses for non-thermal ablation
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11707629B2 (en) 2009-05-28 2023-07-25 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US11723710B2 (en) 2016-11-17 2023-08-15 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11931096B2 (en) 2010-10-13 2024-03-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US11950835B2 (en) 2020-06-29 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
AU2010286535B2 (en) * 2009-08-28 2014-07-17 Medtronic 3F Therapeutics, Inc. Transapical delivery device and method of use
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
JP6563394B2 (en) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド Radially foldable frame for an artificial valve and method for manufacturing the frame
JP6767388B2 (en) 2015-05-01 2020-10-14 イェーナヴァルヴ テクノロジー インコーポレイテッド Devices and methods to reduce the proportion of pacemakers in heart valve replacement
EP3407835A4 (en) 2016-01-29 2019-06-26 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CA3042588A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
WO2018102694A1 (en) 2016-12-01 2018-06-07 Boston Scientific Scimed, Inc. Heart valve remodeling device
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
WO2020093172A1 (en) 2018-11-08 2020-05-14 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
CA3135753C (en) 2019-04-01 2023-10-24 Neovasc Tiara Inc. Controllably deployable prosthetic valve
AU2020271896B2 (en) 2019-04-10 2022-10-13 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CN114025813A (en) 2019-05-20 2022-02-08 内奥瓦斯克迪亚拉公司 Introducer with hemostatic mechanism
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve

Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5713953A (en) * 1991-05-24 1998-02-03 Sorin Biomedica Cardio S.P.A. Cardiac valve prosthesis particularly for replacement of the aortic valve
US5716370A (en) * 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6673090B2 (en) * 1999-08-04 2004-01-06 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US20060020332A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented temporary valve for cardiovascular therapy
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment

Family Cites Families (470)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US4291420A (en) 1973-11-09 1981-09-29 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Artificial heart valve
US3983581A (en) * 1975-01-20 1976-10-05 William W. Angell Heart valve stent
US7018407B1 (en) 1981-10-29 2006-03-28 Medtronic Valve holder for tricuspid heart valve
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
DE3426300A1 (en) 1984-07-17 1986-01-30 Doguhan Dr.med. 6000 Frankfurt Baykut TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS
US4935030A (en) 1985-06-17 1990-06-19 Medtronic, Inc. Mechanical heart valve prosthesis
WO1988000459A1 (en) 1986-07-17 1988-01-28 Quotidian No. 100 Pty. Limited Prosthetic venous valve
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
JP2634431B2 (en) 1987-06-26 1997-07-23 ゼロックス コーポレーション Paper feeder for copier
JPS6483251A (en) 1987-09-24 1989-03-29 Terumo Corp Instrument for securing inner diameter of cavity of tubular organ
IT1218947B (en) 1988-01-12 1990-04-24 Sorin Biomedica Spa CARDIAC VALVE PROSTHESIS
SE8800244D0 (en) 1988-01-27 1988-01-27 Medical Innovation Ab DEVICE FOR CUTTING OF LEFT FLAVORS
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
DK0474748T3 (en) 1989-05-31 1995-05-01 Baxter Int Biological flap prosthesis
CA2033195C (en) 1989-06-19 1994-11-15 Hugh H. Trout, Iii Aortic graft and method for repairing aneurysm
US5290300A (en) 1989-07-31 1994-03-01 Baxter International Inc. Flexible suture guide and holder
FR2657261A1 (en) * 1990-01-19 1991-07-26 Bovyn Gilles Device for temporary implantation of a blood filter in a vein of the human body
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5578071A (en) 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
AR246020A1 (en) 1990-10-03 1994-03-30 Hector Daniel Barone Juan Carl A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms.
US5272909A (en) 1991-04-25 1993-12-28 Baxter International Inc. Method and device for testing venous valves
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5258023A (en) 1992-02-12 1993-11-02 Reger Medical Development, Inc. Prosthetic heart valve
US5234448A (en) 1992-02-28 1993-08-10 Shadyside Hospital Method and apparatus for connecting and closing severed blood vessels
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5982645A (en) 1992-08-25 1999-11-09 Square D Company Power conversion and distribution system
US5265505A (en) 1992-10-29 1993-11-30 Frechette Eugene L Turret-lathe coolant system
US5972030A (en) 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
FR2718951B1 (en) 1994-04-26 1996-07-26 Perouse Implant Laboratoire Tubular stent.
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
FR2728457B1 (en) 1994-12-21 1997-03-21 Franceschi Claude ARTIFICIAL VALVE FOR BLOOD VESSEL
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
DE69635479T2 (en) 1995-06-07 2006-06-08 St. Jude Medical, Inc., St. Paul PROSTHETIC HEARTLAP WITH ENLARGED LUMEN
US6402780B2 (en) 1996-02-23 2002-06-11 Cardiovascular Technologies, L.L.C. Means and method of replacing a heart valve in a minimally invasive manner
US5928916A (en) 1996-04-25 1999-07-27 Medtronic, Inc. Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces
US5741326A (en) 1996-07-15 1998-04-21 Cordis Corporation Low profile thermally set wrapped cover for a percutaneously deployed stent
JP2002501610A (en) 1996-07-19 2002-01-15 リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ Recombinant SEF14 fimbriae protein from Salmonella
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US5895419A (en) 1996-09-30 1999-04-20 St. Jude Medical, Inc. Coated prosthetic cardiac device
US5879320A (en) 1996-12-23 1999-03-09 Cazenave; Craig Richard Implantable vascular device
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US5735859A (en) 1997-02-14 1998-04-07 Cathco, Inc. Distally attachable and releasable sheath for a stent delivery system
EP1011529B1 (en) 1997-03-05 2005-01-26 Boston Scientific Limited Conformal laminate stent device
IL132195A0 (en) 1997-04-11 2001-03-19 Transvascular Inc Method and apparatus for transmyocardial direct coronary revascularization
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US5911734A (en) * 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
DE19731834A1 (en) 1997-07-24 1999-06-17 Ernst Peter Prof Dr M Strecker Implantation device
FR2768324B1 (en) 1997-09-12 1999-12-10 Jacques Seguin SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER
US6361545B1 (en) * 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US5910170A (en) 1997-12-17 1999-06-08 St. Jude Medical, Inc. Prosthetic heart valve stent utilizing mounting clips
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
AU2011699A (en) 1997-12-29 1999-07-19 Ivan Vesely System for minimally invasive insertion of a bioprosthetic heart valve
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US6007557A (en) * 1998-04-29 1999-12-28 Embol-X, Inc. Adjustable blood filtration system
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6250308B1 (en) 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6921811B2 (en) 1998-09-22 2005-07-26 Biosurface Engineering Technologies, Inc. Bioactive coating composition and methods
US6355030B1 (en) 1998-09-25 2002-03-12 Cardiothoracic Systems, Inc. Instruments and methods employing thermal energy for the repair and replacement of cardiac valves
US6540780B1 (en) 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
US20040267349A1 (en) 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
DE19904975A1 (en) 1999-02-06 2000-09-14 Impella Cardiotech Ag Device for intravascular heart valve surgery
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6666886B1 (en) 1999-02-16 2003-12-23 Regents Of The University Of Minnesota Tissue equivalent approach to a tissue-engineered cardiovascular valve
US6110201A (en) 1999-02-18 2000-08-29 Venpro Bifurcated biological pulmonary valved conduit
US6139575A (en) 1999-04-02 2000-10-31 Medtronic, Inc. Hybrid mechanical heart valve prosthesis
US20040044350A1 (en) 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US7226467B2 (en) 1999-04-09 2007-06-05 Evalve, Inc. Fixation device delivery catheter, systems and methods of use
US6666885B2 (en) 1999-04-16 2003-12-23 Carbomedics Inc. Heart valve leaflet
EP1171059B1 (en) 1999-04-23 2005-11-02 St. Jude Medical ATG, Inc. Artificial heart valve attachment apparatus
EP1173116A2 (en) 1999-04-28 2002-01-23 St. Jude Medical, Inc. Heart valve prostheses
WO2000067679A1 (en) 1999-05-06 2000-11-16 Venpro Corporation Implant for restoring venous valvular function
US6309417B1 (en) 1999-05-12 2001-10-30 Paul A. Spence Heart valve and apparatus for replacement thereof
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US6241763B1 (en) 1999-06-08 2001-06-05 William J. Drasler In situ venous valve device and method of formation
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US20030055492A1 (en) * 1999-08-20 2003-03-20 Shaolian Samuel M. Transluminally implantable venous valve
DE10084973T1 (en) 1999-08-27 2002-07-25 Kimberly Clark Co Absorbent object with a folded, expandable, absorbent layer
US6315793B1 (en) 1999-09-08 2001-11-13 Medical Carbon Research Institute, Llc Prosthetic venous valves
DE19945587A1 (en) 1999-09-23 2001-05-10 Co Don Ag Procedure for inserting implants into human organs
US6626930B1 (en) 1999-10-21 2003-09-30 Edwards Lifesciences Corporation Minimally invasive mitral valve repair method and apparatus
JP2001120582A (en) 1999-10-22 2001-05-08 Gunze Ltd Artificial cardiac valve and method of manufacturing the same
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
AU1068800A (en) 1999-11-10 2001-06-06 Impsa International Incorporated Prosthetic heart valve
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
US7018406B2 (en) * 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6709457B1 (en) 1999-11-24 2004-03-23 St. Jude Medical, Inc. Attachment of suture cuff to prosthetic heart valve
SE9904569L (en) 1999-12-14 2001-05-14 Jcl Technic Ab Vascular valve, such as heart valve, and process for its manufacture
CN1204937C (en) 1999-12-24 2005-06-08 东丽株式会社 Catheter with balloon
CN1243520C (en) 2000-01-14 2006-03-01 维亚科公司 Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same
AU3458301A (en) 2000-01-25 2001-08-07 Edwards Lifesciences Corporation Bioactive coatings to prevent tissue overgrowth on artificial heart valves
US6929653B2 (en) * 2000-12-15 2005-08-16 Medtronic, Inc. Apparatus and method for replacing aortic valve
US6872226B2 (en) 2001-01-29 2005-03-29 3F Therapeutics, Inc. Method of cutting material for use in implantable medical device
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US7507252B2 (en) 2000-01-31 2009-03-24 Edwards Lifesciences Ag Adjustable transluminal annuloplasty system
US6821297B2 (en) 2000-02-02 2004-11-23 Robert V. Snyders Artificial heart valve, implantation instrument and method therefor
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20050070999A1 (en) 2000-02-02 2005-03-31 Spence Paul A. Heart valve repair apparatus and methods
US20050267560A1 (en) 2000-02-03 2005-12-01 Cook Incorporated Implantable bioabsorbable valve support frame
US20030229393A1 (en) 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6652583B2 (en) 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
US7083628B2 (en) 2002-09-03 2006-08-01 Edwards Lifesciences Corporation Single catheter mitral valve repair device and method for use
US6869444B2 (en) 2000-05-22 2005-03-22 Shlomo Gabbay Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve
US8366769B2 (en) 2000-06-01 2013-02-05 Edwards Lifesciences Corporation Low-profile, pivotable heart valve sewing ring
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US20050043757A1 (en) 2000-06-12 2005-02-24 Michael Arad Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
WO2001097897A1 (en) 2000-06-20 2001-12-27 Starion Instruments, Inc. Devices and methods for repair of valves in the human body
EP1330189B1 (en) 2000-06-23 2007-12-19 Viacor Incorporated Automated annular plication for mitral valve repair
EP1401358B1 (en) 2000-06-30 2016-08-17 Medtronic, Inc. Apparatus for performing a procedure on a cardiac valve
SE0002514D0 (en) 2000-06-30 2000-06-30 Pacesetter Ab Medical device
AU2001273088A1 (en) * 2000-06-30 2002-01-30 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US7077861B2 (en) 2000-07-06 2006-07-18 Medtentia Ab Annuloplasty instrument
SE0002878D0 (en) 2000-08-11 2000-08-11 Kimblad Ola Device and method of treatment of atrioventricular regurgitation
US6635085B1 (en) 2000-08-17 2003-10-21 Carbomedics Inc. Heart valve stent with alignment posts
US6572652B2 (en) 2000-08-29 2003-06-03 Venpro Corporation Method and devices for decreasing elevated pulmonary venous pressure
US20060142848A1 (en) 2000-09-12 2006-06-29 Shlomo Gabbay Extra-anatomic aortic valve placement
WO2002022054A1 (en) 2000-09-12 2002-03-21 Gabbay S Valvular prosthesis and method of using same
DE10046550A1 (en) 2000-09-19 2002-03-28 Adiam Life Science Ag Prosthetic mitral heart valve consists of support housing with base ring and two stanchions
US8956407B2 (en) 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US20050228422A1 (en) 2002-11-26 2005-10-13 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
WO2004030569A2 (en) 2002-10-01 2004-04-15 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US20060106278A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system
US6893459B1 (en) 2000-09-20 2005-05-17 Ample Medical, Inc. Heart valve annulus device and method of using same
WO2004030570A2 (en) 2002-10-01 2004-04-15 Ample Medical, Inc. Devices for retaining native heart valve leaflet
US20060106279A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop
US8784482B2 (en) 2000-09-20 2014-07-22 Mvrx, Inc. Method of reshaping a heart valve annulus using an intravascular device
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
US6932838B2 (en) 2000-09-29 2005-08-23 Tricardia, Llc Venous valvuloplasty device and method
US6602288B1 (en) 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
DE10049865B8 (en) 2000-10-09 2008-10-30 Universitätsklinikum Freiburg Device for removing an aortic valve on the human heart by means of a minimally invasive surgical procedure
US6918917B1 (en) 2000-10-10 2005-07-19 Medtronic, Inc. Minimally invasive annuloplasty procedure and apparatus
US6913608B2 (en) 2000-10-23 2005-07-05 Viacor, Inc. Automated annular plication for mitral valve repair
US7070618B2 (en) 2000-10-25 2006-07-04 Viacor, Inc. Mitral shield
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6953332B1 (en) 2000-11-28 2005-10-11 St. Jude Medical, Inc. Mandrel for use in forming valved prostheses having polymer leaflets by dip coating
US6730122B1 (en) 2000-11-28 2004-05-04 St. Jude Medical, Inc. Prosthetic heart valve with increased lumen
US6716244B2 (en) 2000-12-20 2004-04-06 Carbomedics, Inc. Sewing cuff assembly for heart valves
US6964682B2 (en) 2000-12-21 2005-11-15 Edwards Lifesciences Corporation Heart valve holder that resist suture looping
US6582448B1 (en) * 2000-12-21 2003-06-24 Advanced Cardiovascular Systems, Inc. Vessel occlusion device for embolic protection system
US6966925B2 (en) 2000-12-21 2005-11-22 Edwards Lifesciences Corporation Heart valve holder and method for resisting suture looping
US6669725B2 (en) 2000-12-28 2003-12-30 Centerpulse Biologics Inc. Annuloplasty ring for regeneration of diseased or damaged heart valve annulus
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US7510576B2 (en) 2001-01-30 2009-03-31 Edwards Lifesciences Ag Transluminal mitral annuloplasty
EP1363559A4 (en) 2001-02-05 2008-10-01 Viacor Inc Apparatus and method for reducing mitral regurgitation
US20050182483A1 (en) 2004-02-11 2005-08-18 Cook Incorporated Percutaneously placed prosthesis with thromboresistant valve portion
US6656221B2 (en) 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
US20020107531A1 (en) 2001-02-06 2002-08-08 Schreck Stefan G. Method and system for tissue repair using dual catheters
US6786924B2 (en) 2001-03-15 2004-09-07 Medtronic, Inc. Annuloplasty band and method
WO2002074201A1 (en) 2001-03-16 2002-09-26 Mayo Foundation For Medical Education And Research Synthethic leaflets for heart valve repair or replacement
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
AUPR389201A0 (en) 2001-03-23 2001-04-12 Lane, Rodney James Improvements in design of external vendus valve stents for the correction fo incompetent vendods valves
US6890353B2 (en) 2001-03-23 2005-05-10 Viacor, Inc. Method and apparatus for reducing mitral regurgitation
US7186264B2 (en) 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US6958076B2 (en) 2001-04-16 2005-10-25 Biomedical Research Associates Inc. Implantable venous valve
US20060069429A1 (en) 2001-04-24 2006-03-30 Spence Paul A Tissue fastening systems and methods utilizing magnetic guidance
US20050125011A1 (en) 2001-04-24 2005-06-09 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
DE10121210B4 (en) 2001-04-30 2005-11-17 Universitätsklinikum Freiburg Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production
US20040193253A1 (en) 2001-04-30 2004-09-30 Thorpe Patricia E Replacement venous valve
US6936067B2 (en) 2001-05-17 2005-08-30 St. Jude Medical Inc. Prosthetic heart valve with slit stent
ITMI20011012A1 (en) 2001-05-17 2002-11-17 Ottavio Alfieri ANNULAR PROSTHESIS FOR MITRAL VALVE
US20020173811A1 (en) 2001-05-21 2002-11-21 Hosheng Tu Apparatus and methods for valve removal
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7377938B2 (en) 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
DE60218179T2 (en) 2001-07-19 2007-11-22 Nymox Corp., Saint-Laurent PEPTIDES FOR THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
US6726716B2 (en) 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US6749630B2 (en) 2001-08-28 2004-06-15 Edwards Lifesciences Corporation Tricuspid ring and template
US6723122B2 (en) 2001-08-30 2004-04-20 Edwards Lifesciences Corporation Container and method for storing and delivering minimally-invasive heart valves
AU2002362442B2 (en) 2001-10-01 2008-08-07 Ample Medical, Inc. Methods and devices for heart valve treatments
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US6726715B2 (en) 2001-10-23 2004-04-27 Childrens Medical Center Corporation Fiber-reinforced heart valve prosthesis
US20040044403A1 (en) 2001-10-30 2004-03-04 Joyce Bischoff Tissue-engineered vascular structures
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US7311729B2 (en) 2002-01-30 2007-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US6805710B2 (en) 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6575971B2 (en) 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US6719784B2 (en) 2001-11-21 2004-04-13 Scimed Life Systems, Inc. Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis
US20050228479A1 (en) 2001-11-29 2005-10-13 Cook Incorporated Medical device delivery system
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US6978176B2 (en) 2001-12-08 2005-12-20 Lattouf Omar M Treatment for patient with congestive heart failure
US6755857B2 (en) 2001-12-12 2004-06-29 Sulzer Carbomedics Inc. Polymer heart valve with perforated stent and sewing cuff
EP1465555B1 (en) 2001-12-21 2015-05-06 QuickRing Medical Technologies Ltd. Implantation system for annuloplasty rings
US6951573B1 (en) 2001-12-22 2005-10-04 Dilling Emery W Prosthetic aortic valve
US20030120340A1 (en) 2001-12-26 2003-06-26 Jan Liska Mitral and tricuspid valve repair
US7201771B2 (en) 2001-12-27 2007-04-10 Arbor Surgical Technologies, Inc. Bioprosthetic heart valve
US6881224B2 (en) 2001-12-28 2005-04-19 St. Jude Medical, Inc. Fatigue test for prosthetic stent
WO2003055417A1 (en) 2001-12-28 2003-07-10 Edwards Lifesciences Ag Delayed memory device
US20030130729A1 (en) 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US7125420B2 (en) 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
CA2477244A1 (en) 2002-02-20 2003-08-28 Francisco J. Osse Venous bi-valve
DE10208202A1 (en) 2002-02-26 2003-09-11 Karlsruhe Forschzent vein graft
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US7048754B2 (en) 2002-03-01 2006-05-23 Evalve, Inc. Suture fasteners and methods of use
US6716241B2 (en) 2002-03-05 2004-04-06 John G. Wilder Venous valve and graft combination
US6797001B2 (en) 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US6719786B2 (en) 2002-03-18 2004-04-13 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7160320B2 (en) 2002-04-16 2007-01-09 The International Heart Institute Of Montana Foundation Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
DE10217559B4 (en) 2002-04-19 2004-02-19 Universitätsklinikum Freiburg Device for minimally invasive, intravascular aortic valve extraction
FR2838631B1 (en) 2002-04-23 2004-12-24 Engeneering And Technological METHOD FOR PRODUCING AN AORTIC OR MITRAL HEART VALVE PROSTHESIS AND AORTIC OR MITRAL HEART VALVE PROSTHESIS THUS OBTAINED
US6761735B2 (en) 2002-04-25 2004-07-13 Medtronic, Inc. Heart valve fixation process and apparatus
AU2003234505A1 (en) 2002-05-03 2003-11-17 The General Hospital Corporation Involuted endovascular valve and method of construction
CA2877641C (en) 2002-05-08 2017-01-17 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US20030229394A1 (en) 2002-06-06 2003-12-11 Ogle Matthew F. Processed tissue for medical device formation
WO2003105667A2 (en) 2002-06-12 2003-12-24 Mitral Interventions, Inc. Method and apparatus for tissue connection
US7666193B2 (en) 2002-06-13 2010-02-23 Guided Delivery Sytems, Inc. Delivery devices and methods for heart valve repair
US7753922B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US7758637B2 (en) 2003-02-06 2010-07-20 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20050216078A1 (en) 2002-06-13 2005-09-29 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US6761734B2 (en) 2002-07-22 2004-07-13 William S. Suhr Segmented balloon catheter for stenting bifurcation lesions
US8172856B2 (en) 2002-08-02 2012-05-08 Cedars-Sinai Medical Center Methods and apparatus for atrioventricular valve repair
JP4929428B2 (en) 2002-08-13 2012-05-09 ロバート・エー・レヴィン Cardiac device and method for percutaneous repair of atrioventricular valve
DE10362367B3 (en) 2002-08-13 2022-02-24 Jenavalve Technology Inc. Device for anchoring and aligning prosthetic heart valves
US7217287B2 (en) 2002-08-28 2007-05-15 Heart Leaflet Technologies, Inc. Method of treating diseased valve
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
CO5500017A1 (en) 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
US20040059412A1 (en) 2002-09-25 2004-03-25 Lytle Thomas William Heart valve holder
US20040060161A1 (en) 2002-09-27 2004-04-01 David Leal Methods of forming a heart valve stent
US7087079B2 (en) 2002-10-10 2006-08-08 Cleveland Clinic Foundation Method and apparatus for replacing a mitral valve with a stentless bioprosthetic valve
US20050119735A1 (en) 2002-10-21 2005-06-02 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
CN1705462A (en) 2002-10-21 2005-12-07 米特拉利根公司 Method and apparatus for performing catheter-based annuloplasty using local plications
CA2502967A1 (en) 2002-10-24 2004-05-06 Boston Scientific Limited Venous valve apparatus and method
US20040082910A1 (en) 2002-10-29 2004-04-29 Constantz Brent R. Devices and methods for treating aortic valve stenosis
GB0225075D0 (en) 2002-10-29 2002-12-04 Smiths Group Plc Valves
ATE363863T1 (en) 2002-11-12 2007-06-15 Myocor Inc DEVICES FOR HEART VALVE TREATMENT
US7247134B2 (en) 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
EP2345380B1 (en) 2002-11-13 2018-01-10 Medtronic, Inc. Cardiac valve procedure devices
WO2004043273A2 (en) 2002-11-13 2004-05-27 Rosengart Todd K Apparatus and method for cutting a heart valve
US20040097979A1 (en) 2002-11-14 2004-05-20 Oleg Svanidze Aortic valve implantation device
AU2003290979A1 (en) 2002-11-15 2004-06-15 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Method and device for catheter-based repair of cardiac valves
FR2847151B1 (en) 2002-11-15 2005-01-21 Claude Mialhe OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION
US6945978B1 (en) 2002-11-15 2005-09-20 Advanced Cardiovascular Systems, Inc. Heart valve catheter
US20040122515A1 (en) 2002-11-21 2004-06-24 Xi Chu Prosthetic valves and methods of manufacturing
US7316708B2 (en) 2002-12-05 2008-01-08 Cardiac Dimensions, Inc. Medical device delivery system
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US20040133240A1 (en) 2003-01-07 2004-07-08 Cardiac Dimensions, Inc. Electrotherapy system, device, and method for treatment of cardiac valve dysfunction
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US6746463B1 (en) 2003-01-27 2004-06-08 Scimed Life Systems, Inc Device for percutaneous cutting and dilating a stenosis of the aortic valve
US7220271B2 (en) 2003-01-30 2007-05-22 Ev3 Inc. Embolic filters having multiple layers and controlled pore size
CN100482187C (en) 2003-01-31 2009-04-29 皇家飞利浦电子股份有限公司 Magnetic resonance compatible stent
US7314485B2 (en) 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040158321A1 (en) 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US8406867B2 (en) * 2003-02-21 2013-03-26 Dtherapeutics, Llc Balloon sizing of valve annulus for percutaneous valves
US20040254600A1 (en) 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
US8157810B2 (en) 2003-02-26 2012-04-17 Cook Medical Technologies Llc Prosthesis adapted for placement under external imaging
EP1603492B1 (en) 2003-03-12 2009-12-23 Cook Incorporated Prosthetic valve that permits retrograde flow
US7381210B2 (en) 2003-03-14 2008-06-03 Edwards Lifesciences Corporation Mitral valve repair system and method for use
US7524332B2 (en) 2003-03-17 2009-04-28 Cook Incorporated Vascular valve with removable support component
US7988679B2 (en) 2003-03-18 2011-08-02 Navilyst Medical, Inc. Pressure responsive slit valve assembly for a plurality of fluids and uses thereof
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
US20040186566A1 (en) 2003-03-18 2004-09-23 Hindrichs Paul J. Body tissue remodeling methods and apparatus
WO2004082530A2 (en) 2003-03-19 2004-09-30 Cook Incorporated Delivery systems for deploying expandable intraluminal medical devices
JP4473861B2 (en) 2003-03-20 2010-06-02 エイオアテック、インターナショナル、ピーエルシー valve
CH696185A5 (en) 2003-03-21 2007-02-15 Afksendiyos Kalangos Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end
SE0300854D0 (en) 2003-03-26 2003-03-26 Oeyvind Reitan Device for the treatment of a heart valve insufficiency
KR100466839B1 (en) 2003-03-28 2005-01-17 주식회사 사이언씨티 Aortic valve Repairing Apparatus Sets and Treatment Method Using The Same
US20050075659A1 (en) 2003-03-30 2005-04-07 Fidel Realyvasquez Apparatus and methods for minimally invasive valve surgery
US20060271081A1 (en) 2003-03-30 2006-11-30 Fidel Realyvasquez Apparatus and methods for valve repair
WO2004089253A1 (en) 2003-04-01 2004-10-21 Cook Incorporated Percutaneously deployed vascular valves
WO2004091449A1 (en) 2003-04-08 2004-10-28 Cook Incorporated Intraluminal support device with graft
US8083707B2 (en) 2003-04-17 2011-12-27 Tosaya Carol A Non-contact damage-free ultrasonic cleaning of implanted or natural structures having moving parts and located in a living body
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7159593B2 (en) 2003-04-17 2007-01-09 3F Therapeutics, Inc. Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation
US6945996B2 (en) 2003-04-18 2005-09-20 Sedransk Kyra L Replacement mitral valve
US7175656B2 (en) 2003-04-18 2007-02-13 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement
US20040210240A1 (en) 2003-04-21 2004-10-21 Sean Saint Method and repair device for treating mitral valve insufficiency
US20040225344A1 (en) 2003-04-23 2004-11-11 Hoffa Andrew K. Devices, kits and methods for placing multiple intraluminal medical devices in a body vessel
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US20040267357A1 (en) 2003-04-30 2004-12-30 Allen Jeffrey W. Cardiac valve modification method and device
US20040220657A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc., A Washington Corporation Tissue shaping device with conformable anchors
US20040220654A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040225356A1 (en) 2003-05-09 2004-11-11 Frater Robert W. Flexible heart valve
DE602004021799D1 (en) 2003-05-19 2009-08-13 Cook Inc IMPLANTABLE MEDICAL DEVICE WITH LIMITED EXPANSION
WO2004103223A1 (en) 2003-05-20 2004-12-02 The Cleveland Clinic Foundation Apparatus and methods for repair of a cardiac valve
EP1628599A4 (en) 2003-05-27 2011-12-28 Viacor Inc Method and apparatus for improving mitral valve function
ATE481057T1 (en) 2003-05-28 2010-10-15 Cook Inc VALVE PROSTHESIS WITH VESSEL FIXING DEVICE
US7007396B2 (en) 2003-05-29 2006-03-07 Plc Medical Systems, Inc. Replacement heart valve sizing device
TW590007U (en) 2003-06-06 2004-06-01 Univ Tamkang Tri-leaflet mechanical heart valve
WO2005004753A1 (en) 2003-06-09 2005-01-20 3F Therapeutics, Inc. Atrioventricular heart valve and minimally invasive delivery systems thereof
US7537600B2 (en) * 2003-06-12 2009-05-26 Boston Scientific Scimed, Inc. Valved embolic protection filter
US20060282161A1 (en) 2003-06-20 2006-12-14 Medtronic Vascular, Inc. Valve annulus reduction system
EP1635724A2 (en) 2003-06-20 2006-03-22 PLC Medical Systems, Inc. Endovascular tissue removal device
US7316706B2 (en) 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
WO2004112652A2 (en) 2003-06-20 2004-12-29 Medtronic Vascular, Inc. Device, system, and method for contracting tissue in a mammalian body
US7537592B2 (en) 2003-06-20 2009-05-26 Plc Medical Systems, Inc. Endovascular tissue removal device
US20040260394A1 (en) 2003-06-20 2004-12-23 Medtronic Vascular, Inc. Cardiac valve annulus compressor system
US8052751B2 (en) 2003-07-02 2011-11-08 Flexcor, Inc. Annuloplasty rings for repairing cardiac valves
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
BRPI0412362A (en) 2003-07-08 2006-09-05 Ventor Technologies Ltd prosthetic implant devices particularly for transarterial transport in the treatment of aortic stenoses and implantation methods for such devices
WO2005007037A1 (en) 2003-07-11 2005-01-27 Vedic Biotechnology, Inc. Selective annuloplasty for atrio-ventricular heart valve regurgitation and devices therefor
NZ527025A (en) 2003-07-16 2007-01-26 David Peter Shaw Prosthetic valves for medical application
WO2005007018A2 (en) 2003-07-16 2005-01-27 The Regents Of The University Of California Thin-film metal alloy biomedical implantable devices
DE602004025954D1 (en) 2003-07-17 2010-04-22 Cordis Corp DEVICES FOR THE PERCUTANEOUS TREATMENT OF AORTIC VALVE STENOSES
US7744620B2 (en) * 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
WO2005007036A1 (en) 2003-07-18 2005-01-27 Brivant Research & Development Limited A device for correcting inversion of the leaflets of a leaflet valve in the heart
WO2005018507A2 (en) 2003-07-18 2005-03-03 Ev3 Santa Rosa, Inc. Remotely activated mitral annuloplasty system and methods
CA2533353A1 (en) 2003-07-21 2005-02-03 The Trustees Of The University Of Pennsylvania Percutaneous heart valve
JP4002293B2 (en) 2003-07-22 2007-10-31 コラゾン テクノロジーズ インコーポレーティッド Apparatus and method for treating aortic valve stenosis
AU2004258950B2 (en) 2003-07-23 2010-11-04 Viacor, Inc. Method and apparatus for improving mitral valve function
US7204255B2 (en) 2003-07-28 2007-04-17 Plc Medical Systems, Inc. Endovascular tissue removal device
DE10334868B4 (en) 2003-07-29 2013-10-17 Pfm Medical Ag Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it
WO2005011535A2 (en) 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
FR2858543B1 (en) 2003-08-08 2006-02-03 Assist Publ Hopitaux De Paris AORTIC AND ANCILLARY RING FOR ITS INSTALLATION
DE10340265A1 (en) 2003-08-29 2005-04-07 Sievers, Hans-Hinrich, Prof. Dr.med. Prosthesis for the replacement of the aortic and / or mitral valve of the heart
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
WO2005027797A1 (en) 2003-09-23 2005-03-31 Ersin Erek A mitral web apparatus for mitral valve insufficiencies
EG24012A (en) 2003-09-24 2008-03-23 Wael Mohamed Nabil Lotfy Valved balloon stent
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US20050096738A1 (en) 2003-10-06 2005-05-05 Cali Douglas S. Minimally invasive valve replacement system
US10219899B2 (en) 2004-04-23 2019-03-05 Medtronic 3F Therapeutics, Inc. Cardiac valve replacement systems
WO2005046528A1 (en) 2003-10-06 2005-05-26 3F Therapeutics, Inc. Minimally invasive valve replacement system
EP1684656B1 (en) 2003-10-17 2016-12-07 Edwards Lifesciences AG Heart valve leaflet locator
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US7258698B2 (en) 2003-10-17 2007-08-21 Medtronic, Inc. Prosthetic heart valve sizer assembly with flexible sizer body
ITBO20030631A1 (en) 2003-10-23 2005-04-24 Roberto Erminio Parravicini VALVULAR PROSTHETIC EQUIPMENT, IN PARTICULAR FOR HEART APPLICATIONS.
DE10350287A1 (en) 2003-10-24 2005-05-25 Deutsche Institute für Textil- und Faserforschung Stuttgart - Stiftung des öffentlichen Rechts Cardiovascular implant, for use as a vascular or heart valve replacement, comprises a non-resorbable polymer formed as a microfiber fleece that allows colonization by a cells
US7070616B2 (en) 2003-10-31 2006-07-04 Cordis Corporation Implantable valvular prosthesis
US7347869B2 (en) 2003-10-31 2008-03-25 Cordis Corporation Implantable valvular prosthesis
US7416530B2 (en) 2003-11-04 2008-08-26 L & P 100 Limited Medical devices
EP1689329A2 (en) 2003-11-12 2006-08-16 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
WO2005046530A1 (en) 2003-11-12 2005-05-26 Medtronic Vascular, Inc. Coronary sinus approach for repair of mitral valve reguritation
WO2005048883A1 (en) 2003-11-13 2005-06-02 Fidel Realyvasquez Methods and apparatus for valve repair
US7740656B2 (en) 2003-11-17 2010-06-22 Medtronic, Inc. Implantable heart valve prosthetic devices having intrinsically conductive polymers
WO2005055811A2 (en) 2003-12-02 2005-06-23 Fidel Realyvasquez Methods and apparatus for mitral valve repair
AU2004296816A1 (en) 2003-12-04 2005-06-23 The Brigham And Women's Hospital, Inc. Aortic valve annuloplasty rings
US7186265B2 (en) 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
US20050177228A1 (en) 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
CA2548541A1 (en) 2003-12-16 2005-06-30 Edwards Lifesciences Ag Device for changing the shape of the mitral annulus
US20050137449A1 (en) 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. Tissue shaping device with self-expanding anchors
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US20050137450A1 (en) 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US7794496B2 (en) 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7261732B2 (en) 2003-12-22 2007-08-28 Henri Justino Stent mounted valve
US7381219B2 (en) * 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US7824442B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US7431726B2 (en) 2003-12-23 2008-10-07 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US8182528B2 (en) * 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US7959666B2 (en) * 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
AU2003299404A1 (en) 2003-12-23 2005-08-11 Laboratoires Perouse Kit which is intended to be implanted in a conduit
US8603160B2 (en) * 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137696A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Apparatus and methods for protecting against embolization during endovascular heart valve replacement
US20050137686A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US20050137691A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US8840663B2 (en) * 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US8343213B2 (en) * 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US7748389B2 (en) * 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US20050149181A1 (en) 2004-01-07 2005-07-07 Medtronic, Inc. Bileaflet prosthetic valve and method of manufacture
WO2005069850A2 (en) 2004-01-15 2005-08-04 Macoviak John A Trestle heart valve replacement
US20050159810A1 (en) 2004-01-15 2005-07-21 Farzan Filsoufi Devices and methods for repairing cardiac valves
US7488346B2 (en) 2004-01-21 2009-02-10 The Cleveland Clinic Foundation Method and apparatus for replacing a mitral valve and an aortic valve with a single homograft
EP1729687A4 (en) 2004-01-22 2007-05-02 Advanced Surgical Design & Man Heart valve
US7320705B2 (en) 2004-01-23 2008-01-22 James Quintessenza Bicuspid pulmonary heart valve and method for making same
US7871435B2 (en) 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
US7597711B2 (en) 2004-01-26 2009-10-06 Arbor Surgical Technologies, Inc. Heart valve assembly with slidable coupling connections
WO2005072652A1 (en) 2004-01-27 2005-08-11 Med Institute, Inc. Anchoring barb for attachment to a medical prosthesis
WO2005076973A2 (en) 2004-02-05 2005-08-25 Children's Medical Center Corporation Transcatheter delivery of a replacement heart valve
US7311730B2 (en) 2004-02-13 2007-12-25 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
WO2005082289A1 (en) 2004-02-20 2005-09-09 Cook Incorporated Prosthetic valve with spacing member
EP1722711A4 (en) 2004-02-27 2009-12-02 Aortx Inc Prosthetic heart valve delivery systems and methods
US7717930B2 (en) 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US20050203549A1 (en) 2004-03-09 2005-09-15 Fidel Realyvasquez Methods and apparatus for off pump aortic valve replacement with a valve prosthesis
US8979922B2 (en) 2004-03-11 2015-03-17 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
JP2007529273A (en) 2004-03-15 2007-10-25 メドトロニック ヴァスキュラー インコーポレイテッド Stent resistant to radial crush
US7942927B2 (en) 2004-03-15 2011-05-17 Baker Medical Research Institute Treating valve failure
US7449027B2 (en) 2004-03-29 2008-11-11 Cook Incorporated Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes
US20050228494A1 (en) 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
US20050222675A1 (en) 2004-04-06 2005-10-06 Sauter Joseph A Implantable prosthetic heart valve comprising a valve body and a tubular vascular graft
US8349001B2 (en) 2004-04-07 2013-01-08 Medtronic, Inc. Pharmacological delivery implement for use with cardiac repair devices
EP1737391A2 (en) 2004-04-13 2007-01-03 Cook Incorporated Implantable frame with variable compliance
US20050240202A1 (en) 2004-04-21 2005-10-27 Hani Shennib Devices and methods of repairing cardiac valves
US20050240255A1 (en) 2004-04-23 2005-10-27 Schaeffer Darin G Carrier-Based Delivery System for Intraluminal Medical Devices
US7641686B2 (en) 2004-04-23 2010-01-05 Direct Flow Medical, Inc. Percutaneous heart valve with stentless support
US20050244460A1 (en) 2004-04-29 2005-11-03 Ivan Alferiev Biodegradable crosslinking strategies using triglycidyl amine (TGA)
US7951196B2 (en) 2004-04-29 2011-05-31 Edwards Lifesciences Corporation Annuloplasty ring for mitral valve prolapse
US7374573B2 (en) 2004-05-03 2008-05-20 Shlomo Gabbay System and method for improving ventricular function
US20050256566A1 (en) 2004-05-03 2005-11-17 Shlomo Gabbay Apparatus and method for improving ventricular function
US7717951B2 (en) 2004-05-06 2010-05-18 Cook Incorporated Delivery system that facilitates visual inspection of an intraluminal medical device
US20060095115A1 (en) 2004-05-10 2006-05-04 Youssef Bladillah Stent and method of manufacturing same
US20060122693A1 (en) 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
US20060122692A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20060122686A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
WO2005112831A2 (en) 2004-05-17 2005-12-01 Fidel Realyvasquez Method and apparatus for percutaneous valve repair
US7785615B2 (en) 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US7803182B2 (en) 2004-05-28 2010-09-28 Cordis Corporation Biodegradable vascular device with buffering agent
GB0414099D0 (en) 2004-06-23 2004-07-28 Univ Glasgow Biocompatible layered structures and methods for their manufacture
WO2006004679A1 (en) 2004-06-29 2006-01-12 The Cleveland Clinic Foundation Prosthetic cardiac valve and method for making same
US7713298B2 (en) 2004-06-29 2010-05-11 Micardia Corporation Methods for treating cardiac valves with adjustable implants
US20080288060A1 (en) 2004-07-06 2008-11-20 Baker Medical Research Institute Treating Valvular Insufficiency
US7422607B2 (en) 2004-08-24 2008-09-09 Oviatt Henry W Anti-calcification treatments for heart valves and vascular grafts
CA2578156A1 (en) 2004-08-26 2006-03-09 Cook Incorporated Delivery system with controlled frictional properties
EP1786367B1 (en) 2004-08-27 2013-04-03 Cook Medical Technologies LLC Placement of multiple intraluminal medical devices within a body vessel
JP4713589B2 (en) 2004-09-01 2011-06-29 クック インコーポレイテッド Delivery system for hydration of intraluminal medical devices
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
FR2874813B1 (en) 2004-09-07 2007-06-22 Perouse Soc Par Actions Simpli VALVULAR PROSTHESIS
CN1745727A (en) 2004-09-08 2006-03-15 王蓉珍 Intercurrent artificial heart valve, its implanting and recovering device
EP1807023A1 (en) 2004-09-10 2007-07-18 Cook Incorporated Prosthetic valve with pores
CA2580053C (en) 2004-09-14 2014-07-08 Edwards Lifesciences Ag. Device and method for treatment of heart valve regurgitation
WO2006034245A2 (en) 2004-09-20 2006-03-30 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US20060064174A1 (en) 2004-09-22 2006-03-23 Reza Zadno Implantable valves and methods of making the same
US7850704B2 (en) 2004-09-27 2010-12-14 Theranova, Llc Method and apparatus for anchoring implants
US6951571B1 (en) 2004-09-30 2005-10-04 Rohit Srivastava Valve implanting device
US20060074483A1 (en) 2004-10-01 2006-04-06 Schrayer Howard L Method of treatment and devices for the treatment of left ventricular failure
JP2008514345A (en) 2004-10-02 2008-05-08 クリストフ・ハンス・フーバー Device for treating or replacing a heart valve or surrounding tissue without requiring full cardiopulmonary support
WO2006041972A2 (en) 2004-10-06 2006-04-20 Cook Incorporated Medical device with bioactive agent
US20060085060A1 (en) 2004-10-15 2006-04-20 Campbell Louis A Methods and apparatus for coupling an allograft tissue valve and graft
WO2006050459A2 (en) 2004-10-28 2006-05-11 Cook Incorporated Methods and systems for modifying vascular valves
US7458987B2 (en) 2004-10-29 2008-12-02 Cook Incorporated Vascular valves having implanted and target configurations and methods of preparing the same
US7641687B2 (en) 2004-11-02 2010-01-05 Carbomedics Inc. Attachment of a sewing cuff to a heart valve
JP2008518706A (en) 2004-11-04 2008-06-05 エル・アンド・ピー・100・リミテッド Medical device
US20060100697A1 (en) 2004-11-10 2006-05-11 Casanova R M Shape memory annuloplasty ring and holder
US20060167468A1 (en) 2004-11-12 2006-07-27 Shlomo Gabbay Implantation system and method for loading an implanter with a prosthesis
WO2006054107A2 (en) 2004-11-19 2006-05-26 Medtronic Inc. Method and apparatus for treatment of cardiac valves
US7744642B2 (en) 2004-11-19 2010-06-29 Biomedical Research Associates, Inc. Prosthetic venous valves
US20060135967A1 (en) 2004-11-22 2006-06-22 Fidel Realyvasquez Method and apparatus for attaching a valve prosthesis
WO2006055982A2 (en) 2004-11-22 2006-05-26 Avvrx Ring-shaped valve prosthesis attachment device
US20060111774A1 (en) 2004-11-24 2006-05-25 Samkov Alexander V Low noise heart valve prosthesis and method for operation
WO2006073628A1 (en) 2004-12-01 2006-07-13 Cook Incorporated Sensing delivery system for intraluminal medical devices
WO2006060546A2 (en) 2004-12-01 2006-06-08 Cook Incorporated Valve with leak path
JP2008522670A (en) 2004-12-06 2008-07-03 サーモディクス,インコーポレイティド Multifunctional medical article
EP1819304B1 (en) 2004-12-09 2023-01-25 Twelve, Inc. Aortic valve repair
US7211110B2 (en) 2004-12-09 2007-05-01 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
US20060127443A1 (en) 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US7410497B2 (en) 2004-12-14 2008-08-12 Boston Scientific Scimed, Inc. Stimulation of cell growth at implant surfaces
SE0403046D0 (en) 2004-12-15 2004-12-15 Medtentia Ab A device and method for improving the function of a heart valve
WO2006064490A1 (en) 2004-12-15 2006-06-22 Mednua Limited A medical device suitable for use in treatment of a valve
WO2006066148A2 (en) 2004-12-16 2006-06-22 Carlos Ruiz A heart valve and method for insertion of the heart valve into a bodily vessel
US7758640B2 (en) 2004-12-16 2010-07-20 Valvexchange Inc. Cardiovascular valve assembly
EP1846078A4 (en) 2004-12-16 2009-12-23 Carlos Ruiz Separable sheath and method of using
EP1848368A1 (en) 2004-12-20 2007-10-31 Cook Incorporated Intraluminal support frame and medical devices including the support frame
US9545300B2 (en) * 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
US7575594B2 (en) 2004-12-30 2009-08-18 Sieracki Jeffrey M Shock dampening biocompatible valve
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060173490A1 (en) * 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) * 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US8012198B2 (en) * 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
EP1988851A2 (en) * 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
JP5604110B2 (en) * 2007-02-05 2014-10-08 ボストン サイエンティフィック リミテッド System for delivering a valve
FR2915678B1 (en) * 2007-05-02 2010-04-16 Lapeyre Ind Llc MECHANICAL PROTHETIC CARDIAC VALVE
US8747458B2 (en) * 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
DE102007056946A1 (en) * 2007-11-27 2009-05-28 Gunnar Pah Device for filtering blood
EP3912597A1 (en) * 2008-02-29 2021-11-24 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US5713953A (en) * 1991-05-24 1998-02-03 Sorin Biomedica Cardio S.P.A. Cardiac valve prosthesis particularly for replacement of the aortic valve
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US5716370A (en) * 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US20050004583A1 (en) * 1997-06-27 2005-01-06 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20040030382A1 (en) * 1999-04-09 2004-02-12 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20040039442A1 (en) * 1999-04-09 2004-02-26 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20050033446A1 (en) * 1999-04-09 2005-02-10 Evalve, Inc. A California Corporation Methods and apparatus for cardiac valve repair
US20050021056A1 (en) * 1999-04-09 2005-01-27 Evalve, Inc. Leaflet structuring
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US6673090B2 (en) * 1999-08-04 2004-01-06 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US6840957B2 (en) * 1999-10-21 2005-01-11 Scimed Life Systems, Inc. Implantable prosthetic valve
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050038507A1 (en) * 2001-05-14 2005-02-17 Alferness Clifton A. Mitral valve therapy device, system and method
US20050033419A1 (en) * 2001-05-14 2005-02-10 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060025787A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060020334A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Methods of cardiac valve replacement using nonstented prosthetic valve
US20060025854A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with formed in place support
US20060025855A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with multiple chamber formed in place support
US20060020327A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented heart valves with formed in situ support
US20060020332A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented temporary valve for cardiovascular therapy
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9918834B2 (en) 2004-09-02 2018-03-20 Boston Scientific Scimed, Inc. Cardiac valve, system and method
US9622859B2 (en) * 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US20150142102A1 (en) * 2005-02-01 2015-05-21 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) * 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US9592137B2 (en) 2005-04-04 2017-03-14 Flexible Stenting Solutions, Inc. Flexible stent
US20110184282A1 (en) * 2005-04-26 2011-07-28 Tockman Bruce A Self-deploying vascular occlusion device
US20060241735A1 (en) * 2005-04-26 2006-10-26 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device
US7935075B2 (en) * 2005-04-26 2011-05-03 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device
US20090069841A1 (en) * 2006-05-23 2009-03-12 Pah Gunnar M Device for Filtering of Blood During Removal of Heart Valve Stenosis and Method of Removing Heart Valve Stenosis
US8758388B2 (en) 2006-05-23 2014-06-24 Gunnar M. Pah Device for filtering of blood during removal of heart valve stenosis and method of removing heart valve stenosis
US20100217175A1 (en) * 2006-05-23 2010-08-26 Pah Gunnar M Device for Filtering of Blood During Removal of Heart Valve Stenosis and Method of Removing Heart Valve Stenosis
US7727254B2 (en) 2006-05-23 2010-06-01 Pah Gunnar M Method of removing heart valve stenosis
WO2007135065A3 (en) * 2006-05-23 2008-02-28 Gunnar M Pah Apparatus for filtering blood when removing a heart valve stenosis, and method for removing a heart valve stenosis
WO2007135065A2 (en) * 2006-05-23 2007-11-29 Pah Gunnar M Apparatus for filtering blood when removing a heart valve stenosis, and method for removing a heart valve stenosis
JP2010517622A (en) * 2007-02-05 2010-05-27 ボストン サイエンティフィック リミテッド System and method for delivering a valve
WO2008097556A1 (en) 2007-02-05 2008-08-14 Boston Scientific Limited Systems and methods for valve delivery
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
WO2009068596A1 (en) * 2007-11-27 2009-06-04 Gunnar Pah Device for filtering blood
US20100305604A1 (en) * 2007-11-27 2010-12-02 Gunnar Pah Device for Filtering Blood
US11607271B2 (en) 2008-04-29 2023-03-21 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US9598691B2 (en) 2008-04-29 2017-03-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US10828086B2 (en) 2008-04-29 2020-11-10 Virginia Tech Intellectual Properties, Inc. Immunotherapeutic methods using irreversible electroporation
US10828085B2 (en) 2008-04-29 2020-11-10 Virginia Tech Intellectual Properties, Inc. Immunotherapeutic methods using irreversible electroporation
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10537379B2 (en) 2008-04-29 2020-01-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10470822B2 (en) 2008-04-29 2019-11-12 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US11890046B2 (en) 2008-04-29 2024-02-06 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US11655466B2 (en) 2008-04-29 2023-05-23 Virginia Tech Intellectual Properties, Inc. Methods of reducing adverse effects of non-thermal ablation
US10286108B2 (en) 2008-04-29 2019-05-14 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US10245105B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Electroporation with cooling to treat tissue
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US11453873B2 (en) 2008-04-29 2022-09-27 Virginia Tech Intellectual Properties, Inc. Methods for delivery of biphasic electrical pulses for non-thermal ablation
US10154874B2 (en) 2008-04-29 2018-12-18 Virginia Tech Intellectual Properties, Inc. Immunotherapeutic methods using irreversible electroporation
US11737810B2 (en) 2008-04-29 2023-08-29 Virginia Tech Intellectual Properties, Inc. Immunotherapeutic methods using electroporation
US10959772B2 (en) 2008-04-29 2021-03-30 Virginia Tech Intellectual Properties, Inc. Blood-brain barrier disruption using electrical energy
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US10010438B2 (en) 2008-10-06 2018-07-03 Flexible Stenting Solutions, Inc. Reconstrainable stent delivery system
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US10292755B2 (en) 2009-04-09 2019-05-21 Virginia Tech Intellectual Properties, Inc. High frequency electroporation for cancer therapy
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11707629B2 (en) 2009-05-28 2023-07-25 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20110137399A1 (en) * 2009-12-02 2011-06-09 Chomas James E Microvalve Protection Device and Method of Use for Protection Against Embolization Agent Reflux
US9295540B2 (en) 2009-12-02 2016-03-29 Surefire Medical, Inc. Dynamic microvalve protection device with associated balloon element for therapeutic intravascular procedures
CN102665608A (en) * 2009-12-02 2012-09-12 神火医药公司 Microvalve protection device and method of use for protection against embolization agent reflux
US8696699B2 (en) 2009-12-02 2014-04-15 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US20120116351A1 (en) * 2009-12-02 2012-05-10 Chomas James E Method of Operating a Microvalve Protection Device
US8696698B2 (en) 2009-12-02 2014-04-15 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US10813739B2 (en) 2009-12-02 2020-10-27 Surefire Medical, Inc. Dynamic microvalve protection device
US9539081B2 (en) * 2009-12-02 2017-01-10 Surefire Medical, Inc. Method of operating a microvalve protection device
WO2011068924A1 (en) 2009-12-02 2011-06-09 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US9808332B2 (en) 2009-12-02 2017-11-07 Surefire Medical, Inc. Dynamic microvalve protection device
US20110130657A1 (en) * 2009-12-02 2011-06-02 Chomas James E Protection Device and Method Against Embolization Agent Reflux
US8500775B2 (en) 2009-12-02 2013-08-06 Surefire Medical, Inc. Protection device and method against embolization agent reflux
EP2506800A4 (en) * 2009-12-02 2016-12-07 Surefire Medical Inc Microvalve protection device and method of use for protection against embolization agent reflux
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
US11931096B2 (en) 2010-10-13 2024-03-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US9770319B2 (en) 2010-12-01 2017-09-26 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US9089668B2 (en) 2011-09-28 2015-07-28 Surefire Medical, Inc. Flow directional infusion device
US9757196B2 (en) 2011-09-28 2017-09-12 Angiodynamics, Inc. Multiple treatment zone ablation probe
US11779395B2 (en) 2011-09-28 2023-10-10 Angiodynamics, Inc. Multiple treatment zone ablation probe
US20130096606A1 (en) * 2011-10-17 2013-04-18 William C. Bruchman Embolic protection devices and related systems and methods
EP2768550A4 (en) * 2011-10-19 2015-06-24 Michael Anthony T Don Apparatus and procedure for trapping embolic debris
US9089341B2 (en) 2012-02-28 2015-07-28 Surefire Medical, Inc. Renal nerve neuromodulation device
US20130345740A1 (en) * 2012-04-30 2013-12-26 BiO2 Medical, Inc. Multi-lumen central access vena cava filter apparatus for clot management and method of using same
US20140257362A1 (en) * 2013-03-07 2014-09-11 St. Jude Medical, Cardiology Division, Inc. Filtering and removing particulates from bloodstream
EP2983614A4 (en) * 2013-04-12 2016-12-14 Michael Anthony T Don Apparatus and procedure for trapping embolic debris
AU2014250845B2 (en) * 2013-04-12 2017-05-04 Don Michael International, Llc Apparatus and procedure for trapping embolic debris
US20150119977A1 (en) * 2013-10-30 2015-04-30 The Regents Of The University Of Michigan System and method to limit cerebral ischemia
US11135361B2 (en) 2014-03-25 2021-10-05 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US9889031B1 (en) 2014-03-25 2018-02-13 Surefire Medical, Inc. Method of gastric artery embolization
US9968740B2 (en) 2014-03-25 2018-05-15 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US11406820B2 (en) 2014-05-12 2022-08-09 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US10471254B2 (en) 2014-05-12 2019-11-12 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US11903690B2 (en) 2014-12-15 2024-02-20 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US11090460B2 (en) 2015-03-31 2021-08-17 Surefire Medical, Inc. Method for infusing an immunotherapy agent to a solid tumor for treatment
CN107530177A (en) * 2015-04-09 2018-01-02 弗里德曼德科技公司 For pre- anti-stroke 3D filters
US20180064525A1 (en) * 2015-04-09 2018-03-08 Frid Mind Technologies 3d filter for prevention of stroke
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
US11723710B2 (en) 2016-11-17 2023-08-15 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11298218B2 (en) 2017-01-20 2022-04-12 W. L. Gore & Associates, Inc. Embolic filter system
US11744692B2 (en) * 2017-02-23 2023-09-05 Boston Scientific Scimed, Inc. Medical drain device
US20180235743A1 (en) * 2017-02-23 2018-08-23 Boston Scientific Scimed, Inc. Medical drain device
US10588636B2 (en) * 2017-03-20 2020-03-17 Surefire Medical, Inc. Dynamic reconfigurable microvalve protection device
US20180263752A1 (en) * 2017-03-20 2018-09-20 Surefire Medical, Inc. Dynamic Reconfigurable Microvalve Protection Device
US20180353280A1 (en) * 2017-06-13 2018-12-13 Dai Yamanouchi Infarction prevention device and treatment method
GB2563880B (en) * 2017-06-28 2022-03-23 Cook Medical Technologies Llc Implantable medical device including valve member
GB2563880A (en) * 2017-06-28 2019-01-02 Cook Medical Technologies Llc Implantable medical device including valve member
US11229438B2 (en) 2017-06-28 2022-01-25 Cook Medical Technologies Llc Implantable medical device including valve member
CN107468379A (en) * 2017-09-11 2017-12-15 姜正明 A kind of aortic valve stent induction system and aortic valve systems
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11382632B2 (en) * 2018-06-27 2022-07-12 Boston Scientific Scimed, Inc. Vascular occlusion device
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port
US11304792B2 (en) * 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device
US11952568B2 (en) 2019-04-05 2024-04-09 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of biphasic electrical pulses for non-thermal ablation
US11950835B2 (en) 2020-06-29 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
CN111938865A (en) * 2020-07-31 2020-11-17 李云松 Filter-related vein hyperplasia intimal cutting catheter
US11957405B2 (en) 2020-10-16 2024-04-16 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation

Also Published As

Publication number Publication date
US20150142102A1 (en) 2015-05-21
WO2006083472A1 (en) 2006-08-10
EP2537486A1 (en) 2012-12-26
EP1855614A1 (en) 2007-11-21
EP1855614B1 (en) 2017-05-31
US9622859B2 (en) 2017-04-18
JP4991572B2 (en) 2012-08-01
EP3245978A1 (en) 2017-11-22
US20160374793A1 (en) 2016-12-29
JP2008528232A (en) 2008-07-31
CA2596296A1 (en) 2006-08-10
EP2537486B1 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
US9622859B2 (en) Filter system and method
US7854755B2 (en) Vascular catheter, system, and method
US9918834B2 (en) Cardiac valve, system and method
US10869764B2 (en) Venous valve apparatus, system, and method
US7967853B2 (en) Percutaneous valve, system and method
JP5687070B2 (en) Stent for prosthetic heart valve
EP1945141B1 (en) Venous valve, system, and method with sinus pocket
US20080269877A1 (en) Systems and methods for valve delivery
US20130345799A1 (en) Valve apparatus, system and method

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAFONTAINE, DANIEL M.;JENSON, MARK L.;DRASLER, WILLIAM J.;REEL/FRAME:016247/0583

Effective date: 20050201

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION